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Metal Oxide Nanoparticles: The Importance of Size, Shape, Chemical 




Nanoparticles, which are defined as a structure with at least one dimension between 1 and 100 
nm, have the potential to be used in a variety of consumer products due to their improved 
functionality compared to similar particles of larger size. Their small size is associated with 
increased strength, improved catalytic properties, and increased reactivity; however, their size is 
also associated with increased toxicity in vitro and in vivo. Numerous toxicological studies have 
been conducted to determine the properties of nanomaterials that increase their toxicity in order 
to manufacture new nanomaterials with decreased toxicity. Data indicates that size, shape, 
chemical composition, and valence state of nanomaterials can dramatically alter their toxicity 
profile. Therefore, the purpose of this dissertation was to determine how altering the shape, size, 
and chemical composition of various metal oxide nanoparticles would affect their toxicity. Metal 
oxides are used in variety of consumer products, from spray-sun screens, to food coloring agents; 
thus, understanding the toxicity of metal oxides and determining which aspects affect their 
toxicity may provide safe alternatives nanomaterials for continued use in manufacturing. 
Tungstate nanoparticles toxicity was assessed in an in vitro model using RAW 264.7 cells. The 
size, shape, and chemical composition of these nanomaterials were altered and the effect on 
reactive oxygen species and general cytotoxicity was determined using a variety of techniques. 
Results demonstrate that shape was important in reactive oxygen species production as wires 
were able to induce significant reactive oxygen species compared to spheres. Shape, size, and 
chemical composition did not have much effect on the overall toxicity of these nanoparticles in 
RAW 264.7 cells over a 72 hour time course, implicating that the base material of the 
nanoparticles was not toxic in these cells. To further assess how chemical composition can affect 
toxicity, cerium oxide nanoparticles were chemically modified using a process known as doping, 
to alter their valence state. The size and shape of the cerium oxide nanoparticles remained 
constant. Overall, results indicated that cerium oxide was not toxic in both RLE-6TN and 
NR8383 pulmonary rat cells, however, chemically modifying the valence state of the 
nanomaterial did affect the antioxidant potential. To determine if this trend was measureable in 
vivo, rats were exposed to various cerium oxide nanoparticles via intratracheal instillation and 
damage, changes in pulmonary cell differentials, and phagocytic cell activity were assessed. 
Results implicate that chemically modifying the nanoparticles had an effect on the overall 
damage induced by the material but did not dramatically affect inflammatory potential or 
phagocytic cell activity. Overall the data from these studies imply that size, shape, chemical 
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1.1 What are Nanoparticles? 
Nanoparticles, or ultrafine particles, are a form of particulate matter (PM) defined as structures 
with at least one dimension between 1 and 100 nm, that have unique characteristics not found in 
bulk material of the same composition [2]. PM, is a complex mixture of particles and liquid 
droplets. Depending on the size of the particles in the PM determines the detrimental health 
effects. Thus, ultrafine particles may have more negative effects due to their increased reactivity 
and surface area compared to coarse (>2.5 µm) or fine (<2.5 µm) PM [3]. Specifically, their 
small size, large surface area-to-volume ratio, strength, chemical composition, surface structure, 
and shape allow for the use of nanomaterials in a variety of commercial and industrial products, 
including batteries, sporting goods, cosmetics, electronics, and even sun-screens [1, 4-7]. Due to 
this versatility, their use in manufacturing and commercial applications has drastically increased 
into a multi-billion dollar industry [1, 8].  
 Nanoparticles are typically grouped into two categories: incidental and engineered. 
Incidental nanoparticles are those produced as a result of an industrial of combustion process, 
typically unintentionally, such as soot as a product of fossil fuel combustion. Alternatively, 
engineered nanomaterials are materials that are intentionally created with specific attributes for 
use in manufacturing, engineering, and consumer products [9]. There are numerous categories of 
engineered nanomaterials currently being produced, ranging from carbon- to metal-based 
nanomaterials, and their potential uses appear endless. This review will discuss 5 common 
nanomaterials, their uses, their potential toxicity, and potential mechanisms to alter toxicity 
while improving function. 
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1.2 Various Types of Nanomaterials 
Carbon-based nanomaterials 
Typically, carbon-based nanomaterials are in the shape of tubes, known as carbon nanotubes 
(CNTs), or hollow spheres, known as fullerenes. These materials are often used in electronics, 
energy storage devices, industrial catalysts, and nanomedicine as a result of their unique shape, 
and large surface area-to-size ratio [10]. The most commonly studied and used carbon-based 
materials are single-walled CNTs (SWCNTs), which are a single layer of carbon in a fibrous 
form, multi-walled CNTs (MWCNTs), which are multiple layers of SWCNTs wrapped together, 
and fullerene C60, which resembles a soccer ball and consists of 60 carbon atoms [11, 12]. 
While their overall uses are plentiful, their use in consumer products may be limited due to 
previous studies indicating severe toxicity and asbestos-like pathogenicity observed in animal 
models induced following CNT exposure [13-16].  
 
Polymer-based nanomaterials 
Other nanomaterials that have uses in nanomedicine are polymer-based nanomaterials. These can 
consist of materials from plastics to proteins and DNA and show promise for quick drug delivery 
due to easy cell entry. Further, polymer-based nanomaterials are useful in food packaging as they 
can improve the barrier and antimicrobial properties of the packaging as well as be used as 
sensors to monitor the condition of the food [17]. Unlike many other nanomaterials available, 
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Ceramic-based nanomaterials 
Ceramic-based nanomaterials are highly sought for use in engineering, due to their improved 
physical and mechanical properties, compared to their bulk-sized counterparts. For instance, 
magnesium aluminum can be used in harsh conditions due to an improved melting point and is 
ideal for lenses due to enhanced optical properties [20]. Further, they are useful as bioactive 
coatings on prosthetics and are important in tissue repair and implants [21]. Unfortunately, like 
many nanomaterials, their toxicity is not fully understood, but due to their degradation potential, 
the potential to cause damage is likely [8, 22].  
 
Metal-based nanomaterials 
Metal-based nanomaterials have received a lot of attention over the years, mainly nanosilver, 
which is known to act as an antibacterial agent and is estimated to have the greatest number of 
commercial applications. Currently these nanomaterials are used in a variety of medical 
applications, such as contraceptives and are used to treat burns and wounds [8]. They are also 
being added to various household products such as paint, tooth paste, fabrics, and toys for their 
antimicrobial properties [23]. Other metal-based nanomaterials commonly used are quantum dots 
and nanogold. Nanogold has found use in immunolabeling as well as tumor imaging due to 
increased penetration into tissues, greater sensitivity, and improved labeling [24, 25]. The 
toxicity of metal-based nanomaterials has been heavily studied with many studies concluding 
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Metal oxide-based nanomaterials 
Metal oxide-based nanomaterials, such as zinc oxide (ZnO) and titanium dioxide (TiO2), are 
currently used in a variety of consumer products, such as sunscreen or in donuts and cosmetics 
for coloring [4]. Metal oxide-based nanomaterials are also useful for a variety of engineering 
purposes, such as use in circuits, fuel cells, catalysts, and sensors [27]. Unlike metal-based and 
ceramic-based nanomaterials, metal oxide nanomaterials are typically very toxic, induce high 
levels of reactive oxygen species (ROS) and inflammation, and pose significant health risks [28-
30]. This is due to the effect of size on electronic properties of the metal oxide. While the 
decrease in size is beneficial for stability, it can affect the electronic properties and reactivity of 
the nanomaterial, resulting in new, unstudied toxicological outcomes [27]. The effect of size on 
metal oxide nanoparticles reactivity has been studied in depth and it was determined that a 
change in band gap, or the difference in charge between the tissue and the nanomaterials, had a 
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1.3 Possible Exposure Routes 
As a result of the varying types of engineered nanomaterials and the products in which they are 
manufactured in, the potential routes of human exposure can differ greatly. However, the 
common routes of exposure are gastric, dermal, intravenous, or inhalation.  
 
Gastric Exposure 
Exposures to nanomaterials via the gastrointestinal tract represents a likely exposure route due to 
the use of various nanomaterials in both food and food containers. Further, following inhalation 
of nanomaterials, the materials may be indirectly ingested following movement up the 
mucociliary escalator and into pharynx where it is then swallowed. Silver nanoparticles are one 
material that has potential to be exposed via gastric routes due to its use in agriculture as a 
replacement for growth-promoting antibiotics [32]. Further, TiO2 nanomaterials are used in a 
variety of consumer products for pigmentation, often for food coloration, providing a direct path 
for ingestion of the nanomaterials. Fortunately, studies have implicated that nanomaterials 
exposed through gastrointestinal routes typically result in mild toxicity and relatively high 
concentrations [33].   
 
Dermal Exposure 
Use of nanomaterials in consumer products, such as make-up and sunscreens provides a direct 
route of exposure for nanomaterials to enter biological systems via the skin. Further, dermal 
exposure represents a risk for workers during the manufacturing of products containing 
nanomaterials. TiO2 nanoparticle studies have presented data that these nanomaterials are able to 
penetrate rodent skin and even result in organ damage. [34]. However, this effect was not 
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measured in humans [35]. Further, studies implicate that nanoparticles administered in the 
dermis migrated toward lymph nodes, which may result in immunomodulation. In general, 
studies indicate that unless lesions are present within the dermal layer, human health hazards to 
dermal nanoparticle penetration are limited.  
 
Intravenous Exposure 
As a result of nanomaterials potential use in medicine, intravenous exposure (IV) is another 
prospective exposure route of interest. Silica based nanomaterials have been studied following 
IV exposure as this material is emerging as a promising candidate for biomedical applications. 
Research has indicated that overall silica nanomaterials have low toxicity potential via IV 
exposure routes [36]. Further, CNTs, which have potential uses in cancer treatment and drug 
delivery, accumulate in various organs but induce mild damage following IV exposure in mice 
[37]. In general, IV exposure results in nanomaterial organ accumulation but mild toxicity. 
 
Inhalation Exposure 
The most likely route of exposure humans are likely to contact nanomaterials in through an 
inhalation route, due to properties of the materials that allow them to disperse readily in air [38]. 
Further, occupational environments in which nanomaterials are used for consumer products 
provides a likely scenario for nanoparticle inhalation. Studies have indicated that various 
nanomaterials cause significant toxicity in vivo following inhalation exposures, resulting in 
cellular influx, inflammation, and changes in lung structure and function [22, 39, 40]. For this 
reason, as well as a lack of toxicity data for most nanomaterials, understanding the potential 
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1.4 Toxic Potential of Nanomaterials 
Nanomaterials provide numerous benefits for the engineering and consumer product industries, 
yet their potential human health effects are still under investigation to ensure safe manufacturing 
of nano containing products. While some nanomaterials cause little to no toxicity in vitro and in 
vivo at physiologically relevant doses, many nanomaterials have significant adverse effects, such 
as inflammation, genotoxicity, ROS production, and cell death.  
 
Inflammation 
Inflammation, which is typically associated with cytokine activation, changes in physiological 
environment, and changes in cellular composition, is a common endpoint induced by 
nanoparticles both in vitro and in vivo [22, 40]. In animal models, persistent inflammation is 
known to promote fibrotic changes and induce permanent pulmonary damage [41]. Metal oxide 
nanomaterials, such as ZnO, are typically strong inducers of inflammation, as measured by 
cytokine production [42]. Further, silica nanoparticles are able to induce pro-inflammatory 
markers in both monocyte-derived macrophages (RAW 264.7) and mice following single 
exposures [22]. Following inhalation exposures to TiO2, mice presented with emphysema-like 
lung injury, likely in response to inflammatory pathway activation [43].  
 
Genotoxicity 
In addition to promoting inflammation, studies have also been conducted to understand the 
genetic damage nanomaterials can induce. A strong inducer of genotoxicity in vitro are various 
metal oxide-based nanomaterials, such as copper oxide (CuO) and ZnO, which have been shown 
to induce genotoxicity in various cell lines, such as human lung epithelial cells and human 
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epidermal cells [44, 45]. Further, cerium oxide (CeO2) nanoparticles has been shown to induce 
genotoxicity in human dermal fibroblasts, likely as a result of ROS production while TiO2 
research has presented evidence that these nanomaterials cause genotoxic damage in mice [46-
48]. While metal oxide-based nanomaterials are typically inducers of genotoxicity, various other 
nanomaterials such as nickel nanoparticles and carbon-based nanomaterials have also been 
shown to cause genetic damage [49, 50]. 
 
ROS Production 
ROS is often measured to determine the extent of nanoparticle toxicity. This is due to the idea 
that nanoparticles have a large surface area-to-size ratio, creating a more reactive surface. 
Further, the use of transition metals often creates electron donor and acceptor active sites on the 




 is the main ROS produced in vivo and 
has strong reducing and oxidizing properties. In addition, O2
.-
 production can lead to amplified 
free radical generation and downstream damage due to the production of hydroxyl radicals (
.
OH) 
(Figure 1.1) [1, 51].  
Figure 1.1 Schematic showing effect of superoxide production on downstream hydroxyl radical production and 
subsequent damage to lipids, DNA, and proteins.  
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Numerous studies have provided evidence that ZnO nanoparticles induce significant ROS 
in various cell lines and in animals, possibly due to the dissolution properties exhibited by these 
nanoparticles [29, 52, 53]. Further, CuO nanoparticles are also known to induce significant ROS 
production by overwhelming cellular antioxidant systems [54]. Conversely, studies have also 
implicated that certain nanomaterials, such as platinum and CeO2, may have antioxidant-like 
effects, acting similar to superoxide dismutase (SOD), glutathione reductase (GSH), or catalase, 
preventing ROS induced damage from other chemicals [55, 56].  
 
Cell Death 
To determine the extent of nanoparticle toxicity beyond inflammatory potential or ROS 
production, cell death is commonly studied to determine toxic doses of nanomaterials. While 
many nanomaterials induce ROS or inflammation, this is not always correlated with cell death 
due to protective cellular mechanisms, such as antioxidant systems [57]. Therefore, to 
understand nanoparticle toxicity, various concentrations are tested in vitro and in vivo to 
determine the dose at which nanomaterials become harmful. Two typical methods of cell death 
are induced by nanomaterials: apoptosis and necrosis (Figure 1.2).  Apoptosis is a normal 
process that occurs during cell turnover, is typically tightly controlled, and is considered a type 
of programmed cell death, which requires specific signals to be promoted [58]. Alternatively, 
cells can undergo necrotic cell death which is considered to be energy-independent and a result 
of severe toxic insult. Further, the cellular contents released during apoptotic cell death induce 
little to no inflammation, whereas the contents released following necrosis are highly 
inflammatory and can result in further downstream cellular damage. ZnO nanoparticles have 
been shown to typically induce apoptotic cell death whereas gold nanoparticles are implicated in 
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necrotic cell death [59-61]. Alternatively, some nanomaterials, such as silver, have been 
implicated in both forms of cell death, likely due to changes in experimental conditions (tissue 
type, concentration, exposure time), as apoptotic cell death can transition toward necrotic cell 









Figure 1.2 Schematic showing two common types of cell death: Necrosis and Apoptosis. Necrotic cells experience 
swelling due to a compromised cell membrane and eventually lyse, releasing cellular contents into the surrounding 
environment. Apoptotic cells shrink and begin to bleb, eventually forming apoptotic cell bodies which contain all of 
the cellular contents and are eventually phagocytosed by surrounding cells.   
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1.5 Characteristics of Nanoparticle Toxicity 
Effect of Size on Nanoparticle Toxicity 
As noted, nanomaterials are any structure with at least one dimension between 1 and 100 nm [2]. 
While this feature improves the material’s use in engineering, it can have dramatic effects on 
cytotoxicity and cellular uptake [64-66]. This is due to small changes in size leading to drastic 
changes in surface area and subsequent increases in the amount of cell-nanomaterial interaction 
(Figure 1.3) [1].  
A study completed by Park et al. (2011) implicated that smaller silver nanoparticles (20 nm) 
were more toxic than their larger counterparts (80 and 113 nm) in L929 fibroblasts as they 
induced greater inflammation, and had more pronounced effects on genotoxicity and 
developmental toxicity endpoints [67]. Studies have also indicated that nanoparticle size effects 
ROS formation. Specifically, 15 nm silver nanoparticles induced significant ROS production in 
NR8383 macrophages whereas 50 nm silver nanoparticles did not [68]. Similar data were 
collected in osteoblastic mouse MC3T3-E1 cells, and phaeochromocytoma-derived PC12 cells, 
Figure 1.3 Inverse relationship between particle size and number of molecules displayed on the surface, showing that 
as nanoparticle size decreases the amount of molecules on the surface increases. For example, 30 nm particles have 
about 10% of the molecules expressed whereas a 3 nm particle has approximately 50% of the molecules expressed on 
the surface (Adapted from [1]). 
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as silver nanoparticle size decreased, the ability of the particles to induce apoptosis increased 
[69]. Further, A549 human epithelial cells exposed to various sized ZnO and titanium dioxide 
nanoparticles, showed a similar trend that as size increased, toxicity decreased [70].   
 Nanomaterial size not only affects cytotoxicity but can alter cell death pathways. Gold 
nanoparticles have been shown to induce either necrosis or apoptosis depending on size, and the 
larger the particles become, the less measureable the toxicity they produce [71]. Unfortunately, 
as with many in vitro toxicity studies, little unison is seen with size effects in vivo [72]. Zhang et 
al. (2011) presented data in which various PEG-coated gold nanoparticles were administered to 
mice via intraperitoneal injection. Unlike in vitro studies that have concluded the size of gold 
nanoparticles alters toxicity, data from this study were inconclusive in regards to the effect of 
size on nanoparticle toxicity [73]. TiO2 nanoparticles showed similar conflicting data in vivo, as 
increased particle size was associated with increased toxicity as opposed to decreased toxicity in 
vitro [74]. Larger silica nanoparticles have also been shown to induce greater inflammation in 
mice following intravenous injection than smaller silica nanoparticles [75]. While these results 
are conflicting, it is possible that due to the large surface area of the nanoparticles, they readily 
agglomerate in vivo, thus mitigating the expected effects of size on toxicity [66]. Based on 
previous studies and a need to further the understanding of how nanomaterial size alters 
reactivity, a comparison of different sized nanomaterials was assessed and is discussed in this 
dissertation.   
 
Effect of Shape on Nanoparticle Toxicity 
Nanomaterials can be made in a variety of shapes depending on their function and purpose, such 
as rods, spheres, cylinders, and cubes. These changes in shape, just like size, can affect cellular 
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uptake and subsequent toxicity [64, 65]. Chithrani et al. (2006) determined that nano-sized 
spherical particles are taken up by cells more readily than nanorods [76]. A similar finding was 
presented by Heng et al. (2011) in which ZnO spheres associated with cells more readily 
compared to ZnO sheets [77]. Further, numerous studies have shown differences in reactivity of 
carbon-based nanomaterials. While these nanomaterials are composed of graphene, a honeycomb 
lattice of carbon atoms, the shape of the materials drastically alters toxicity. Jia et al (2005) 
presented in vitro toxicity data that C60 fullerenes were much less toxic compared to both 
SWCNTs and MWCNTs and had less effects on phagocytosis impairment in alveolar 
macrophages [78]. Studies comparing MWCNTs to carbon nanofibers (CNFs) also found 
differences in toxicity profiles, implicating that MWCNTs were less toxic than CNFs in various 
lung tumor cell lines [13]. Zhang et al. (2010) presented similar findings in PC12 rat cells where 
both graphene layers and SWCNTs induced toxicity, but the SWCNTs caused greater elevations 
in lactate dehydrogenase (LDH) levels [79]. 
  Additionally, metal oxide nanoparticles are known to induce varying degrees of toxicity 
dependent on shape. Results from Hsiao and Huang (2011) showed that ZnO nanorods induced 
greater toxicity in A549 human lung epithelial cells compared to nanospheres when surface area 
and size were held constant. Further, results indicated that titanium dioxide nanoparticle shape 
was also important in toxicity and that amorphous TiO2 induced greater toxicity than both 
anatase or anatase/rutile nanoparticles [70]. Based on previous studies and a need to further the 
understanding of how nanomaterial shape alters reactivity, a comparison between sphere and 
wire toxicity was assessed and is discussed in this dissertation.   
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Effect of Chemical Composition on Nanoparticle Toxicity 
In addition to shape and size, changes in nanomaterial composition can also affect toxicity. A 
study completed by Limbach et al. (2007) compared the toxicity of silica nanoparticles 
containing various metals. The nanomaterials were of similar size, shape, and agglomeration, 
which allowed for assessment of importance of chemical composition on toxicity. Results 
demonstrate that alterations in solubility and catalytic potential of the nanomaterials could alter 
the intracellular effects [80]. Similar studies have been conducted comparing metal oxide 
nanoparticles of similar size and have implicated that toxicity is dependent on chemical 
composition [61]. Further, Mihalchik et al. (2015) presented evidence that altering the chemical 
composition of MWCNT with nitrogen affects reactivity. The addition of nitrogen to the 
MWCNT carbon lattice caused increased ROS production, possibly due to changes in surface 
reactivity [14]. Based on previous studies, the effect of chemical composition of nanoparticles 
was assessed and is discussed in this Dissertation.  
 
Effect of Valence State on Nanoparticle Toxicity 
While chemical composition can modify the toxicological profile of nanomaterials, altering the 
valence state of nanomaterials can also affect their cellular response. Valence state refers to the 
number of electrons an atom can use for bonding. Some transition and post-transition metals can 
have more than one valence state; depending on the specific valence state can affect the metals 
reactivity. For example, cerium (Ce), a rare earth metal, can exist in a dual valence state of 3+ 
and 4+ due to the inner and outer electron shells nearly equal energy. Due to the similar energy 
levels, little energy is required to transition between the two different electronic levels allowing 




[81]. Interestingly, the valence state of this 
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material has profound effects on its reactivity in vitro. Researchers have implicated that altering 




 decreases the antioxidant-like effects of cerium oxide (CeO2) 
nanoparticles as previously determined [82, 83]. Further, Auffan et al. (2008) presented data that 
the valence state of iron nanoparticles affected their toxicity toward Escherichia coli. 
Specifically, changes in valence state affected the generation of ROS and disturbed the electron 
transport train due to interaction with oxygen molecules on the nanoparticle surface [84]. 
Adjusting the valence state of nanoparticles may provide a mechanism to decease their toxic 
potential, thus, the effect of valence state on CeO2 nanoparticle toxicity was assessed in this 
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Figure 1.4. Diagram of the process of doping. In order to adjust the valence state of nanomaterials, often a technique 
known as doping is utilized. This is the process of adding impurities (i.e. gadolinium) into a pure substance to 
modulate the electrical properties. When impurities are added, the number of oxygen vacancies in the nanomaterial 
changes and the valence state is pushed toward that of the added impurity. By increasing the oxygen vacancies in the 
molecule, this improves electrical conductivity and oxygen storage ability [85], potentially increasing the reactivity 
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1.6 Dissertation 
The purpose of this study was to investigate how, size, shape, chemical composition, and valence 
state alters various metal oxide nanoparticle toxicity.  
 
Chapter 2. Assess how size, shape, and chemical composition of tungstate nanoparticles 
affects their toxicity in RAW 264.7 cells.  
Tungstate nanoparticles, which can be used in fluorescent lighting and gas sensors [86], are a 
type of metal oxide nanoparticle that is predicted to increase in manufacturing. Therefore, to 
determine the toxicity of tungstate nanoparticles and develop safer tungstate containing 
materials, the shape, size, and chemical composition of the nanoparticles were altered. Using 
cytotoxicity assays and measurements of oxidative stress, the effects of size, shape, and chemical 
composition were assessed in RAW 264.7 cells.  
 
Chapter 3. Assess how valence state of cerium oxide (CeO2) nanoparticles alters reactivity 
in pulmonary rat cells.  
The toxicity of CeO2 nanoparticles, which can be used in a variety of applications, including an 
additive to diesel fuel to decrease diesel admissions, is currently debated as some studies show 
mild to no toxicity and other studies implicate CeO2 induces severe toxicity [83, 87, 88]. Based 
on previous studies [82, 83], the hypothesis that CeO2 would have greater antioxidant-like effects 
in a pure, unmodified form was assessed using RLE-6TN rat alveolar epithelial cells and 
NR8383 rat alveolar macrophage cells. Various cytotoxicity and oxidative stress assays were 
utilized to determine how doping, a process which modifies the valence state of CeO2, would 
affect the reactivity of the nanoparticles.  
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Chapter 4. Assess how valence state of cerium oxide (CeO2) nanoparticles alters reactivity 
following intratracheal instillation in rats. 
Previous research has implied that CeO2 causes adverse biological effects in rat models, inducing 
pulmonary PMN infiltration, cell death, and changes in collagen remodeling [39, 40, 89-91]. 
Based on these experiments, the hypothesis that pure CeO2 would induce greater toxic effects in 
vivo compared to doped CeO2 was tested. Cell differentials, cell death, oxidative damage, and 





















The Effect of Tungstate Nanoparticles on Reactive Oxygen Species and 
Cytotoxicity in RAW 264.7 Mouse Monocyte Macrophage Cells 
 
Citation: Dunnick K, Badding M, Schwegler-Berry D, Patete J, Koenigsmann C, Wong S, and Leonard S. The effect 
of tungstate nanoparticles on reactive oxygen species and cytotoxicity in RAW 264.7 mouse monocyte macrophage 












Adapted from Journal of Toxicology and Environmental Health Part A, 2014, 77 (20): 1251-
1268 
- 22 - 
 
Abstract 
Due to their size, surface area, and chemical characteristics, nanoparticle use in consumer 
products has increased. However, the toxicity of nanoparticle exposure during the manufacturing 
process has not been fully assessed. Tungstate nanoparticles can be used in numerous products, 
including but not limited to scintillator detectors and fluorescent lighting. As with many 
nanoparticles, few toxicity studies have been completed. We tested the hypothesis that tungstate 
nanoparticle cellular exposure would result in reactive oxygen species (ROS) formation and 
cytotoxicity. We also hypothesized that differences in toxicity would occur based on tungstate 
nanoparticle size, shape (sphere vs. wire), and chemical characteristics. RAW 264.7 mouse 
monocyte macrophages were treated with tungstate nanoparticles and ROS formation was 
assessed via Electron Paramagnetic Resonance (EPR), and several assays (hydrogen peroxide, 
intracellular ROS, and Comet). Results showed ROS production induced by tungstate nanowire 
exposure and DNA damage induced by tungstate nanospheres. Cells were treated over 72 hours 
to assess cytotoxicity using an MTT assay. Results showed that differences in cell death between 
wires and spheres occurred at 24 hours but were minimal at both 48 and 72 hours. The present 
results imply that tungstate nanowires are capable of inducing ROS and cell death within 24 
hours of exposure, whereas nanospheres do not, suggesting that differences in shape may affect 
reactivity. Although differences between spheres and wires were measured, after 24 hours, 
neither shape causes substantial cell death. Thus, tungstate nanoparticles may represent a safer 
alternative to other potentially more toxic metal oxides currently used in industry. 
 
Key Words: Nanotoxicology, Metal Oxides, Reactive Oxygen Species, Cytotoxicity, Toxicity 
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Introduction 
Nanoparticles are defined as any structure with one dimension between 1 and 100 nm [2]. 
Their small size and large surface area-to-volume ratios offer physical and chemical properties 
not necessarily found in larger particles of similar chemical composition. For these reasons, 
increases in their manufacturing as well as in their commercial application and use have been 
rising dramatically. It is therefore important to understand potential risks associated with their 
use. Such activity may result in novel occupational exposures and potential health hazards that 
are dependent on the toxicity of the nanoparticle. For example, nanoscale zinc oxide (ZnO) is 
currently being used in sunscreens to remove the unpleasant white-film commonly associated 
with sunscreen application [4]. Unfortunately, studies have shown that while nano-sized ZnO is 
useful in sunscreen coloring, the reduced size also may result in increased toxicity [92, 93]. Due 
to the potential for toxicity, it is important to assess if the benefits of nanomaterials are indeed 
worth the health risks. 
Nanoscale metal oxides represent one such material for which an increase in their usage 
has been noted. Currently they are incorporated as components of gas sensors, as they increase 
performance and reduce instabilities observed with their polycrystalline counterparts [5]. 
However, their unique properties have been speculated to be partly responsible for their 
biological toxicology. Metal oxides, for example, are widely known for their semi-conducting 
properties, allowing for passive electron transfer between the nanomaterial and aqueous 
environments. This passive electron transfer is thought to play a role in toxicity as it may occur 
between the metal oxides and the biological system, thereby promoting oxidative stress and 
inflammation [31]. Current research has shown that metal oxide nanoparticles are capable of 
inducing reactive oxygen species (ROS) formation which can result in oxidative stress, DNA 
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damage, and down-stream health effects such as inflammatory responses [31, 93-95]. Studies 
have also shown metal oxides induce lactose dehydrogenase leakage and apoptosis at low doses 
and necrosis at high concentrations [61].  
The growing use of nanomaterials in consumer products has resulted in increased 
industrial manufacturing. Tungstate nanoparticles, whose possible applications include 
fluorescent lighting, scintillator detectors, and gas sensors [7, 86], represent one such metal oxide 
that may be associated with increased manufacturing activity in the future. However, to date, 
limited studies have been performed on tungstate nanoparticle toxicity. Therefore, our study 
focused on assessing the toxicity of six different alkaline earth metal tungstate nanowires and six 
different nanospheres AWO4 (A = Ca, Sr, Ba) in an in vitro model. Further, research has shown 
that nanoparticles of similar or identical chemical composition can vary in toxicity based on size 
or shape [96]. Thus, we were intent on examining how differences in size, shape, and chemical 
composition would correlate with toxicity.  
Based on previous studies that have shown metal oxide toxicity in RAW 264.7 cells [77, 
97], we hypothesized that tungstate nanoparticle exposure would generate ROS and promote cell 
death. Further, we hypothesized that differences in size and shape of the nanoparticles would 
affect toxicity. 
 
Materials and Methods 
Cell culture 
RAW 264.7 mouse monocyte macrophage cells (ATCC; Rockville, MD) were cultured 
following the ATCC recommended protocol. Cells were cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM) with 2 mM L-glutamine, 10% fetal bovine serum, and 50 mg/ml 
penicillin/streptomycin (Thermo Scientific; Pittsburgh, PA). Cells were grown at 37
o 
C in a 5% 
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CO2 incubator and were passaged by scraping into medium. RAW 264.7 cells were chosen for 
these studies because they react with and engulf particles.  
 
Tungstate nanoparticle production and characterization 
Nanoparticle production and characterization were completed by Dr. Stanislaus Wong, Dr. 
Christopher Koenigsmann, and Dr. Johnathan Patete. Experimentally, a commercially available, 
track-etched polycarbonate membrane, possessing pores with an average diameter of 50 nm, was 
mounted between two halves of a U-shaped reaction tube. Each half contained aqueous precursor 
solutions of defined chemical composition, which were allowed to diffuse towards each other, so 
as to control the resulting spatially confined growth of the corresponding anisotropic 
nanoparticles within the hollow membrane pore channels. For example, in a typical synthesis of 
tungstate nanowires, one of the two half cells was filled with Na2WO4 solution, and the other 
half cell contained a solution of the metal salt (either CaCl2, SrCl2, or Ba(NO3)2), to 
correspondingly generate CaWO4, SrWO4, and BaWO4 nanowires [86].  
 For the agglomerates of tungstate nanospheres, the synthesis was accomplished by 
solution phase precipitation of the appropriate alkali earth metal salt (either CaCl2, SrCl2, or 
Ba(NO3)2) and sodium tungstate Na2WO4 [98]. 
 Purity was assessed using X-ray diffraction (XRD), and dimensions (diameter and length) 
of the nanoparticles were determined using a field emission scanning electron microscopy (SEM) 
instrument [86]. To prepare XRD samples, the tungstate nanoparticles were rendered into slurries 
in ethanol, sonicated, and subsequently air dried as a film upon deposition onto glass slides. 
Multiple, replicate diffraction patterns were collected using a Scintag diffractometer (Scintag 
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Inc.; Cupertino, CA), operating in the Bragg-Brentano configuration using Cu Kα radiation (λ = 
1.54 Å) from 10° to 80° at a scanning rate of 2°/minutes. 
 The dimensions as well as morphology of as-prepared tungstate nanoparticles were 
characterized using a field emission scanning electron microscopy instrument (FE-SEM Leo 
1550), operating at an accelerating voltage of 15 kV and equipped with energy-dispersive X-ray 
spectroscopy (EDS) capabilities. Samples for SEM were prepared by dispersing as-prepared 
tungstate nanoparticles in ethanol, sonicating for about 2 minutes, and then depositing a dilute 
solution of the sample onto either a conductive tape or a silicon wafer, attached to a SEM brass 
stub. All of these samples were then conductively coated with gold by sputtering for 15 s so as to 
minimize charging effects under SEM imaging conditions. 
 Agglomeration and size distribution of tungstate nanoparticles in a suspended state were 
assessed using dynamic light scattering (DLS). DLS analyzes the velocity distribution of 
suspended particles by detecting fluctuations of light scattering intensity caused by Brownian 
motion of the particles. This technique yields a hydrodynamic radius or diameter of the particles. 
Tungstate nanoparticles were prepared in dispersion media at concentrations of 100 µg/ml and a 
Nanotrac 252 (Microtrac; Montgomeryville, PA) was used to assess diameter and agglomeration.  
 
Determination of cellular interaction  
RAW 264.7 cells were grown on cleaned, autoclaved cover-glass until 60-80% confluent 
(Chemglass Life Sciences; Vineland, New Jersey). Tungstate nanoparticles were prepared in 
dispersion media at a stock concentration of 1 mg/ml, as previously described [99]. Cells were 
then treated with tungstate nanoparticles at a final concentration of 10 µg/ml for 5 minutes, 1 
hour, 3 hours, and 7 hours in serum-free media. Following incubation, the media was removed 
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and the cells were washed 3 times with warm phosphate buffered saline (PBS), fixed with 10% 
formalin for 10 minutes, washed 3 times with PBS, mounted with Fluoromount G, and sealed 
with clear nail polish. Slides used for this experiment were purchased as clean cut slides to 
prevent excess silica particle residue, which results in excessive background during imaging 
(Schott Nexterion; Arlington, VA). Following mounting, images were acquired at 60x 
magnification using a Cytoviva enhanced darkfield microscopy system (Aetos Technologies; 
Inc., Auburn, AL) integrated into an Olympus BX41 upright optical microscope equipped with 
an Olympus DP73 digital camera (Olympus; Center Valley, PA). An enhanced darkfield 
microscope allows visualization of nano-sized particles that would otherwise not be visible under 
typical light microscopy [100]. Cellular interaction was determined as the number of cells 
associated with particles relative to the number of cells not associated with particles. The relative 
association is expressed as a percentage.  
For SEM, RAW 264.7 cells were grown on cleaned, autoclaved cover-glass until 60-80% 
confluent (Chemglass Life Sciences; Vineland, New Jersey). Tungstate nanoparticles were 
prepared in dispersion media at a stock concentration of 1 mg/ml and cells were treated at a final 
concentration of 10 µg/ml tungstate nanoparticles in serum-free media for 3 hours. Following 
exposure, cells were washed 3 times with warm PBS to remove unbound particles. The samples 
were fixed in formalin and post-fixed in osmium tetroxide. They were dehydrated in an ethanol 
series, dried using hexamethyldisalizane, mounted onto aluminum stubs, and sputter-coated with 
gold/palladium so as to render them conductive.  The samples were then imaged on a Hitachi S-
4800 field emission scanning electron microscope (Hitachi High Technologies America; Inc., 
Clarksburg, MD). Elemental analysis was performed on samples to ensure particles associated 
with cells were tungstate nanoparticles using an energy dispersive system attachment. The 
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electron beam was pointed at the area of the sample to be analyzed, resulting in an X-ray spectra 
of characteristic of the elemental composition of the sample. Only elements present within the 
area will be emitted and recorded on the spectral graph.  
Determination of cellular engulfment 
Transmission electron microscopy (TEM) was completed by Mrs. Diane Schwegler-Berry. For 
TEM, RAW 264.7 cells were grown in 6 well dishes until confluent. Cells were treated with 
tungstate nanoparticles at 50 µg/ml for 3 hours in serum-free media. Following exposure, media 
was removed and cells were scraped into 1 ml PBS, and centrifuged at 500xG for 5 minutes. The 
samples were then fixed in Karnovsky’s (2.5% gluteraldehyde, 2.5% paraformaldehyde in 0.1 M 
Sodium Cacodylic buffer) fixative, post-fixed in osmium tetroxide, mordanted in 1% tannic acid, 
and stained en bloc in 0.5% uranyl acetate. The pellets were embedded in epon, sectioned, and 
stained with Reynold’s lead citrate and uranyl acetate. The sections were imaged on a JEOL 
1220 transmission electron microscope (Jeol; Peabody, MA). 
 
Electron Paramagnetic Resonance (EPR) 
A spin trap technique was used to form long-lived free radicals that could be detected by EPR 
through addition of DMPO (5,5’-dimethylpyrroline N-oxide). EPR measurements were collected 
using a flat cell assembly and Brüker EMX spectrometer (Billerica, MA). Tungstate 
nanoparticles were incubated at a final concentration of 1 mg/ml with 1 mM H2O2 and 100 mM 
DMPO (Sigma Chemical Co.; St. Louis, MO) for 3 minutes as previously described [101]. 
Samples were run in triplicates. Signal intensity (peak height) is used to measure the relative 
amount of hydroxyl radicals produced and is measured in mm. 
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 For cellular EPR, tungstate nanoparticles at a final concentration of 1 mg/ml were 
incubated with RAW 264.7 cells at 2x10
6
 cells/ml and 200 mM DMPO for 5 minutes at 37
o 
C 
[101]. Peak heights represent relative amounts of hydroxyl radicals produced, and are measured 
in mm. 
 
Hydrogen peroxide production 
RAW 264.7 cells were seeded at 1x10
5
 cells per well in 96 well plates and allowed to grow for 
24 hours until approximately 60% confluent. Assays were completed using recommended 
company protocol (OXIS International; Foster City, CA). Briefly, cells were treated with 
tungstate nanoparticles at a final concentration of 50 μg/ml for 5 minutes or 1 hour. Following 
treatment, 10 μl media was removed from the centrifuged 96 well plate and combined with 90 μl 
of working reagent. Following a 30 minute incubation, absorbance was measured at 560 nm. 
Samples were run in triplicates and experiments were completed twice. Data reported as 
percentage absorbance compared to control.  
 
Intracellular ROS production 
RAW 264.7 cells were seeded at 5x10
4
 cells per well in 96 well plates and allowed to grow for 
24 hours until approximately 50% confluent. The assay was completed using the recommended 
company protocol (Cell Biolabs, Inc.; San Diego, CA). Briefly, 2’, 7’-Dichlorodihydrofluorescin 
diacetate (DCFH-DA), diluted in serum-free medium, was added to cells following removal of 
media and 3 washes with PBS and incubated for 45 minutes at 37
o
C. Following incubation, the 
media was removed, cells were washed with PBS, and serum-free media was added to wells with 
tungstate nanoparticles at a final concentration of 50 μg/ml. Control wells were run containing 
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only media and tungstate nanoparticles to measure potential auto-fluorescence, but none was 
detected above the fluorescence of the blank. Measurements were recorded every hour at 480 nm 
excitation/ 530 nm emission. Data reported in DCF fluorescence units.  
 
Comet assay 
RAW 264.7 cells were seeded at 1x10
5
 in 24 well plates and grown until 50% confluent. Cells 
were treated with tungstate nanoparticles at a final concentration of 50 μg/ml for 1 or 3 hours. A 
comet assay was completed using an alkaline system as outlined by the company (Trevigen; 
Gaithersburg, MD). Briefly, cells were washed with PBS, combined with pre-heated agarose, 
and placed on comet slides. Samples were lysed, treated with an unwinding solution, and 
electrophoresed at 21 V, 50 mAmps for 50 minutes. Following fixation with 70% ethanol and an 
overnight drying stage, slides were treated with SYBR green and imaged using an Olympus 
AX70 microscope equipped with an Olympus DP73 digital camera (Olympus; Center Valley, 
PA). Experiments were completed in duplicate and a minimum of 50 comets were measured for 
percentage DNA in comet tails. These measurements were calculated using ImageJ software to 
compare the corrected nuclear region fluorescence to the corrected total cell fluorescence as 




Cells were seeded at 2.5x10
4 
cells per well in 96 well plates. Following 24 hours of growth, cells 
were treated with tungstate nanoparticles at a final concentration of 50 μg/ml for 24, 48, or 72 
hours. Four hours prior to each time point, media was removed and replaced with 100 μl phenol 
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red-free medium containing 0.5 mg/ml  MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) (Invitrogen; Carlsbad, CA). At the various time points, 50 μl of 
media was removed and replaced with 100 μl dimethyl sulfoxide (DMSO) (Fisher Scientific; 
Pittsburgh, PA) to solubilize the formazan crystals, mixed, and incubated for 10 minutes at 37
o 
C. 
Absorbance was measured at 570 nm. Data reported as percent absorbance compared to the 
control.  
 
Caspase 3/7 assay 
RAW 264.7 cells were seeded at 1x10
5
 cells per well in 96 well plates. Following 24 hours 
growth, cells were treated with tungstate nanoparticles at a final concentration of 50 µg/ml for 24 
hours. The caspase 3/7 assay was completed according to company protocol (Invitrogen; 
Carlsbad, CA). Thirty minutes prior to the 24 hour time point, 5 μM caspase 3/7 reagent was 
added to the wells and incubated at 37
o 
C. Fluorescence was measured at 502 excitation/ 530 
emission. Data reported as percent fluorescence compared to control. 
 
Statistical Analysis 
All data are represented as the mean ± standard deviation for each condition. To compare 
responses between groups, a one-way analysis of variance (ANOVA) and Tukey post-test were 
performed using GraphPad Prism 6 software (GraphPad Software; Inc., La Jolla, CA). Statistical 









Analysis by XRD indicated that all 12 tungstate nanoparticle samples were pure and contained 
no detectable crystalline impurities, which is in agreement with previous reports [86]. SEM 
images provided length and size characteristics of the six different spheres and six different wires 
(Table 2.1, Figure 2.1). All six agglomerates of nanospheres were of different sizes, and the 
individual nanoparticles that comprise the nanospherical agglomerates were approximately 20 
nm in diameter. Most notably, agglomerates of BaWO4 spheres measured greater than 1 µm in 
diameter and 4 µm in length while the remaining agglomerated spheres were less than 400 nm in 
diameter and less than 122 nm in length. All six nanowires were of similar diameter, 
approximately 100 nm, and of similar length, approximately 2 µm. Although the measured 
diameters were found to be significantly larger than the nominal pore size of the template, 
expansion of the pore walls during nanowire growth is typical under U-tube conditions, 
particularly for polycarbonate membranes. The diameter of the nanowire is in agreement with 
previous reports [104-106].  
DLS was used to assess particle size under the physiological treatment conditions used in 
cellular exposures. Results showed the nanospheres existed in 2 populations, large and small 
with the exception of BaWO4 and Ca7Sr3WO4 nanospheres, which dispersed into a single size 
population (Figure 2.1A). In suspension, BaWO4 population size was smaller than that measured 
under dry conditions, possibly a result of the non-spherical shape.  DLS cannot accurately define 
the diameter of non-spherical nanoparticles, but provides a representative measurement of the 
wires relative sizes and provides an indication of dispersion state [107]. Results for nanowires 
showed that with the exception of SrWO4 and BaWO4, all other nanowires formed large 
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agglomerations with diameters between 200 nm and 6000 nm. On the other hand, SrWO4 and 
BaWO4 nanowires had diameters around 1 nm, which implies they did not form large 
agglomerates (Figure 2.1). 
 
Cellular Interactions with Particles Show Accumulation Over Time 
To investigate potential tungstate nanoparticle cellular interactions, we used enhanced darkfield 
microscopy to visualize both spheres and wires with RAW 264.7 cells over a time course of 7 
hours. Results showed that both spheres and wires accumulated on the cell surface over the time 
course (Figure 2.2). However, the wires associated with cells more rapidly as compared with the 
spheres as noted at 1 and 3 hour time points. Figure 2.2A shows that after 1 hour, SrWO4, 
Ca3Sr7WO4, Ca5Sr5WO4, and Ca7Sr3WO4 tungstate spheres were significantly associated with 
cells, relative to PBS vehicle-treated cells. Conversely, after 1 hour, all tungstate wires, with the 
exception of BaWO4, were significantly associated with cells relative to PBS vehicle control 
cells (Figure 2.2B).   
 
Cellular Engulfment of Tungstate Nanoparticles 
To study whether tungstate-cellular interactions were associated with engulfment of 
nanoparticles after 3 hours, TEM was implemented. Tungstate nanospheres were visualized 
within the cells, while nanowires were not. Images showed that the nanospheres were engulfed 
and possibly confined to cytoplasmic vacuoles rather than existing free in the cytoplasm (Figure 
2.3). TEM images showed no engulfment of nanowires after 3 hours. Based on the lack of TEM 
confirmation of nanowire engulfment, SEM analysis was performed to determine if the wires 
attach to and penetrate the cell surface. Only Ca3Sr7WO4, and Ca7Sr3WO4 wires could be 
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verified as being associated with cells (Figure 2.4); however, examination of cells showed 
increased cellular debris following exposure to all tungstate nanowires suggesting the cells are 
likely reacting to the presence of wires. SEM showed that nanowires were either lying on top of 
the cells or were protruding into the cells. Elemental analysis was completed to confirm the 
particles associated with the cells were actually tungstate nanowires (Figure 2.4B). 
 
Hydroxyl Radical Production from Tungstate Nanoparticles 
Based on the visualization of particle-cellular interactions and previous studies highlighting 
metal oxide-induced ROS production [108], hydroxyl radical production was measured. To 
determine whether tungstate nanoparticles are capable of converting H2O2 to hydroxyl radicals, 
acellular Fenton reactions were carried out using EPR and a spin trap method. Both spheres and 
wires were capable of producing hydroxyl radicals in an acellular system, with SrWO4 wires 
producing significantly more hydroxyl radicals as compared with SrWO4 spheres (Figure 2.5A). 
Because hydroxyl radicals are highly reactive oxygen species, their production provides a basis 
for cellular damage, and thus cellular EPR was also completed. The data showed that the 
majority of the spheres yielded no hydroxyl radical production, whereas wires still produced 
hydroxyl radicals (Figure 2.5B). However, the hydroxyl radical peak height by wires decreased 
under cellular conditions relative to acellular production (e.g., Ca3Sr7WO4: 57.8 ± 5.0 mm for 
H2O2 versus 33.2 ± 6.7 mm for cellular, mean±SD).  
 
Tungstate Nanoparticles do not Cause Hydrogen Peroxide Release 
Based on the EPR results, we chose to examine H2O2 production as another means of measuring 
ROS. To assess the release of H2O2 from cells, media was measured after 5 minute and 1 hour 
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treatments with tungstate nanoparticles. Figure 2.6 shows no H2O2 production at either time 
point following cellular treatment with both wires and spheres as compared with PBS controls.  
 
Tungstate Nanowires Induce Intracellular ROS  
To further explore ROS induction following tungstate nanoparticle exposure, intracellular ROS 
production was assessed using a cell permeable dye, DCFH-DA, which fluoresces in the 
presence of ROS. Cells were treated with tungstate nanoparticles (wires and spheres) and 
measurements were taken every hour for 7 hours. Out of all 6 spheres, only Ca7Sr3WO4 
treatment with cells resulted in significantly increased intracellular ROS production as compared 
with PBS controls (PBS, 1610.5±438.08, Ca7Sr3WO4, 3148.1±1332.2 at 4 hours, Figure 2.7A). 
Wire-treated cells showed significant ROS production relative to PBS controls starting at 5 hours 
exposure with all 6 tungstate wires (Figure 2.7B).  
 
Tungstate Nanosphere Exposures Cause DNA Damage 
 
To measure potential DNA damage following nanoparticle exposure, an alkaline comet assay 
was used [109]. A comet assay uses an unwinding and electrophoresis process to produce comet 
‘tails’, which are formed following nuclear DNA damage. Cells treated with spheres for 3 hours 
had slight but significant DNA damage as compared with respective PBS controls, whereas cells 
treated with wires for 3 hours had no significant DNA damage (Figure 2.8). Additionally, a time 
course study showed DNA damage to be highest at 3 hours of exposure, with no significant 
changes at 1 hour exposure. Basal levels of DNA damage in PBS control cells were higher in the 
wire exposed experiment compared to the sphere exposed treatment. 
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Tungstate Nanoparticle Treatments Result in Minimal Decreases in Cell Viability 
 
To measure overall cell viability following nanoparticle exposure, an MTT assay was used[96]. 
At 24 hours, cellular treatment with spheres showed a trend towards increased cell viability or 
potentially enhanced proliferation as compared with PBS-treated controls. In contrast, cellular 
exposure to wires showed a trend towards decreased viability as compared with PBS controls at 
the same time point (Figure 2.9A). At 48 hours, these changes in viability were no longer 
present with either wires or sphere-treated cells, with the exception of Ca3Sr7WO4 wires, which 
was significantly lower as compared with both PBS vehicle control cells and Ca3Sr7WO4 sphere-
treated cells (wire: 74.9±8.8%, PBS control: 100.0±6.1%, sphere: 111.6±23.0%, Figure 2.9B). 
At 72 hours, cellular exposure to Ca3Sr7WO4, Ca5Sr5WO4, and Ca3Sr7WO4 wires caused slight 
but significant reductions in viability as compared with PBS vehicle control cells (Figure 2.9C). 
No significant differences were measured at 72 hours with sphere exposures. We wanted to 
determine if these slight decreases in viability at 24 hours treatment were due to apoptosis. 
Therefore we measured caspase 3/7 activation. Measurements showed no caspase 3/7 activation 




Metal oxide nanoparticles are increasing in use due to their unique chemical properties. 
In response to this growth in manufacturing, there is concern for potential toxicity following 
exposure during processing. Decreased size and increased surface area have been implicated in 
nanoparticle toxicity, especially when compared with their larger counterparts as previously 
shown [94]. Therefore, this study focused on understanding how differences in shape and size 
- 37 - 
 
could affect the toxicity of 6 different tungstate nanowires and 6 different tungstate nanospheres 
in an in vitro model. 
The principal finding of the present study was that tungstate nanowires reacted with 
RAW 264.7 cells and resulted in ROS production and cell death after 24 hours at 50 µg/ml, 
while nanospheres did not induce significant ROS or cell death at the same concentration 
(Figures 2.4, 2.6, and 2.8). These differences may be due to the increased surface area, inherent 
anisotropic character and the size of the wires relative to spheres [1, 110, 111]. Size was also an 
important factor in the ability of nanoparticles to associate and interact with cells; agglomerates 
of BaWO4 spheres were the largest tungstate nanoparticles tested and had the least amount of 
cellular association over the 7 hour time course. BaWO4 spheres were not visualized by TEM 
within the cells either. Moreover, these spheres were also less reactive, implying that increased 
size and a lack of cellular association and engulfment may affect toxicity. Furthermore, Zhao et 
al. showed that increased cellular association with nanoparticles results in differences in ROS 
production [112]. Therefore, the increased cellular associations noted with wires compared to 
spheres, as visualized with enhanced darkfield microscopy (Figure 2.2), may be responsible for 
the differences in ROS production.  
While enhanced darkfield imaging showed nanowire-cellular association, both SEM and 
TEM analyses could not confirm that all 6 wires were engulfed by or associated with cells. The 
intrinsic morphology of the cells rendered differentiation between wires and pseudopodia 
difficult. Additionally, the small size of the wires may have hindered spectral analysis. While 
SEM could only confirm that Ca3Sr7WO4 and Ca7Sr3WO4 wires were associated with cells and 
appear to be penetrating the cells, the presence of cellular debris in images of wire-treated cells 
implies that this treatment may cause some form of cellular damage (Figure 2.4). Large fiber or 
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wire-like particles, such as asbestos, have previously been shown to lack full engulfment by 
cells. Rather, association typically results in frustrated phagocytosis, which can cause ROS 
production [113]. Given our finding that tungstate nanowires were more reactive than spheres 
and produced continued ROS over a 7 hour time course with cells, we speculate that the fiber-
like shape contributes to cellular stress. The lengths of tungstate nanowires are shorter than 
typical fibers that result in frustrated phagocytosis [114] and therefore probably do not result in 
true frustrated phagocytosis. However, their protrusion into the cell and continued association 
rather than engulfment may cause similar cellular responses, such as ROS, as measured through 
EPR and an intracellular ROS assay. Based on the increased ROS generation by wires, we 
expected to see a significant increase in oxidative DNA damage by wires relative to spheres [96]. 
Unexpectedly, we observed minimal DNA damage following wire incubation with cells over a 3 
hour time course. Further, we noted minimal but significant DNA damage following sphere 
incubation with cells at 3 hours. This indicates that tungstate nanoparticles do not induce long-
term cellular oxidative injury, regardless of ROS production by cells exposed to wires (Figure 
2.8).  
Furthermore, a discrepancy in toxicity between wires and spheres was noted through an 
MTT assay. The spheres cause a trend towards increased viability and potential cell proliferation 
with 24 hours of treatment. Conversely, the cells treated with wires had decreased viability at 24 
hours, which was significant compared to both vehicle control cells and spheres. This decrease in 
viability could be in response to the damaging ROS measured via both EPR and the intracellular 
ROS assay (Figures 2.4, 2.6). Studies have shown that ROS-induced damage can result in 
cytotoxicity through mitochondrial damage and the promotion of apoptosis [61]. Because we 
anticipated cell death was due to apoptosis, we measured caspase 3/7 levels following cellular 
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interactions with wires or spheres. Based on ROS activity following cellular interactions with 
wires and decreased viability, we anticipated increased caspase 3/7 activation in wire-treated 
cells as compared with sphere-treated cells. However, caspase 3/7 activation was not detected in 
either sphere or wire treatments, implying that cell death was not in response to caspase 
signaling, but rather is occurring via a caspase-independent cell death pathway (Figure 2.9D). 
Surprisingly, at 48 hours of treatment, we observed neither cell death nor increased proliferation 
following wire and sphere treatment with cells, implying that the damage induced by tungstate 
nanoparticle exposure is short-term and manageable by the cells.  
While our results showed minimal toxicity, there are numerous other endpoints of 
nanoparticle toxicity that are commonly measured, including cytokine production and 
inflammation which can propagate disease. For example, Heng et al. showed pro-inflammatory 
cytokine production following ZnO nanoparticle exposure, even with minimal cytotoxic effects 
[77]. Additionally, this group showed that the shape of ZnO nanoparticles played a role in ROS 
production and cytokine release. We thus predicted that perhaps the ROS generation in response 
to nanowire treatments would promote cytokine production by cells. However, there was no 
measurable production of IL-6, IL-8 or TNF-α (data not shown) following treatment, suggesting 
that the mild ROS production caused by tungstate nanowires does not result in an inflammatory 
response by macrophage cells in our toxicity model. 
 Previous studies have shown that treatment of cells with nanoparticles can result in ROS 
production, cellular toxicity, inflammatory responses, and apoptosis [93, 115]. While our study 
showed that tungstate nanowires are capable of producing mild ROS and inducing cytotoxicity 
within 24 hours, our studies in general provide evidence that tungstate nanoparticles may be 
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unreactive in cell culture, unlike other previously-studied metal oxide nanoparticles [22, 93, 116, 
117].  
Due to dosages used in previous nanoparticle research [97], we expected tungstate 
nanoparticles to produce ROS when exposed to RAW 264.7 cells at a concentration of 50 µg/ml. 
However, macrophage cells are capable of engulfing particles to limit the level of toxicity. 
Therefore RAW 264.7 cells appear to be capable of dealing with the toxic effects of tungstate 
nanoparticles at this concentration, such as ROS production and initial decreased viability 
following wire exposure. It is possible that at higher concentrations more negative toxic effects 
would be observed [118]. However, higher doses will no longer fall within the commonly 
accepted concentration range of  0.1-100 µg/ml used in nanotoxicology studies [61, 115]. 
Additionally, longer exposures have been shown to result in greater toxicity, and thus increased 
toxicity may be seen in long-term cell culture [119]. However, our study was interested in acute 
exposures to examine the initial cellular responses to tungstate nanoparticles.  
 Prior to this study, little was known about the toxicity of tungstate nanoparticles. Our 
initial findings imply that at concentrations of 50 µg/ml, tungstate nanoparticles result in mild, 
but repairable damage. Furthermore, these results show that shape and size play a major role in 
determining reactivity, as wires produced more ROS and decreased viability at 24 hours as 
compared with spheres, while chemical composition had minimal effects on differences in 
toxicity. Also, these results demonstrated that chemical characteristics and variability had little 
discernible effect on observed differences in cellular toxicity. The goal of this study was to 
assess whether tungstate nanoparticles would present a hazard that could be translated into 
occupational exposures. This research implies that in an in vitro model, the toxicity of tungstate 
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nanoparticles is minimal. Thus, tungstate nanoparticles may serve as a safe alternative to other 





























Tungstate Nanoparticle Descriptive Characteristics  
 
   LENGTH (nm) 
SAMPLE MORPHOLOGY DIAMETER 
(nm) 
LARGE SMALL 
CaWO4 Spheres 141 +/- 59 328 +/- 
144 
85 +/- 36 
SrWO4 Spheres 356 +/- 111 804 +/- 
365 
32 +/- 18 





Spheres 209 +/- 81 278 +/- 99 54 +/- 17 
Ca5Sr5WO4
* 
Spheres 229 +/- 90 320 +/- 
151 
122 +/- 59 
Ca7Sr3WO4
* 
Spheres 394 +/- 195 394 +/- 
195 
43 +/- 18 
CaWO4 Nanowires 109 +/- 31 2430 +/- 
672 
N/A 
SrWO4 Nanowires 119 +/- 26 2116 +/- 
1178 
N/A 















Nanowires 97 +/- 17 2056 +/- 
1461 
N/A 
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Figure 2.1. Tungstate nanoparticle Dynamic Light Scattering and Electron Microscopy 
Images. A. DLS was completed on tungstate nanospheres to provide diameters of the spheres in 
a dispersed state. B. SEM was completed on tungstate nanospheres to provide length and size 
characteristics in a dry state. From top to bottom: CaWO4, SrWO4, BaWO4, Ca3Sr7WO4, 
Ca5Sr5WO4, Ca7Sr3WO4. C. As in B except SEM was completed on analogous tungstate 
nanowires. All scale bars, 300 nm, except: B: second panel from top, 100 nm, third panel from 
top, 3 µm. 





Figure 2.2. Raw 264.7 cells associate with tungstate nanoparticles over a time course. A. A 
CytoViva enhanced darkfield microscopy system provides images of high-contrast tungstate 
nanoparticles (bright spots) against a dark background of cells. Experiments were completed in 
duplicate and a minimum of 50 cells were counted from 3 fields for each time point. Bars 
represent number of cells associated compared to number not associated as a percentage ± 
standard deviation. *, p<0.001 compared to PBS vehicle, +, p<0.05 compared to PBS vehicle, #, 
p<0.05 compared to 5 minutes, ¥, p<0.05 compared to one hour, ‡, p<0.05 compared to 3 hours. 
C. Representative images of cells treated with Ca3Sr7WO4 nanospheres over a 7 hour time-
course. B. As in A, except cells were treated with tungstate nanowires. D. As in C, except 
images represent cells treated with CaWO4 nanowires over a 7 hour time-course. Scale bar, 10 
µm. 










Figure 2.3. RAW 264.7 cells engulf tungstate nanospheres. TEM analysis of RAW 264.7 cells 

















Figure 2.4. SEM analysis shows wire-cell interactions. A. RAW 264.7 cells were treated with 
Ca7Sr3WO4 tungstate nanowires for 3 hours. B. Elemental analysis was completed on 
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Figure 2.5. Tungstate nanoparticles produce hydroxyl radicals after H2O2 exposure. A. 
EPR settings were: center field, 3385 G; scan width, 100 G; time constant, 0.25 seconds; 
modulation amplitude, 1G; receiver gain, 2.5x10
4
; frequency, 9.424 GHz; and power, 50 mW. 
Signal intensity was measured in mm. Error bars represent the mean ± standard deviation. ¥, 
p<0.05 compared to spheres. B. The same as in A, except tungstate nanoparticles were combined 
with RAW 264.7 cells (2x10
6
). EPR settings were: center field, 3475 G; scan width, 100 G; time 
constant, 0.41 seconds; modulation amplitude, 1G; receiver gain, 2.5x10
4
; frequency, 9.748 
GHz; and power, 126.6 mW. Error bars represent the mean ± standard deviation. 







Figure 2.6. Tungstate nanoparticles do not cause release of cellular H2O2. A. RAW 264.7 
cells were treated with tungstate nanoparticles at 50 µg/ml for 5 minutes. Bars represent the 
percentage H2O2 production as compared with PBS control treated cells ± standard deviation. *, 
p<0.05 compared to PBS vehicle, ¥, p<0.05 compared to spheres, n=6. Cr (VI) at 1 mM was 
used as a positive control. B. Same as in A except cells were treated for 1 hour. 
 







Figure 2.7. Tungstate nanowires produce intracellular ROS.  A. RAW 264.7 cells were pre-
treated with DCFH-DA, then exposed to tungstate nanospheres at 50 µg/ml and incubated at 37
o
 
C for 7 hours. Error bars represent mean ± standard deviation. *, p<0.05 compared to PBS 
vehicle, n=6. Cr (VI) at 1 mM was used as a positive control. B. Same as in A except cells were 










Figure 2.8. Tungstate nanospheres result in oxidative DNA damage at 7 hours. A. RAW 
264.7 cells were treated with tungstate nanoparticles at 50 µg/ml for 7 hours. Percent DNA in the 
tail was measured by comparing nuclear fluorescence with total fluorescence from images. Error 
bars represent the mean ± standard deviation. *, p<0.001 compared to PBS vehicle, #, p<0.05 
compared to PBS vehicle, n=6. Cr (VI) at 1 mM was used as a positive control. B. 
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Figure 2.9. Tungstate nanowires reduce cell viability at 24 hours. A. RAW 264.7 cells were 
treated with tungstate nanoparticles at 50 µg/ml for 24 hours, MTT was added 4 hours prior to 
time point, and absorbance measured. Error bars represent the mean ± standard deviation. * 
p<0.05 compared to PBS vehicle, ¥ p<0.05 compared spheres, n=6. B. As in A except cells were 
treated for 48 hours. C. As in A except cells were treated for 72 hours. D. RAW 264.7 cells were 
treated with tungstate nanoparticles at 50 µg/ml for 24 hours, 5 µM Caspase-3/7 Green Detection 
Substrate was added, and fluorescence measured. Error bars represent the mean ± standard 
deviation. ¥, p<0.05 compared to spheres. 
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Abstract 
Cerium oxide (CeO2) nanoparticles, which are used in a variety of products including 
solar cells, gas sensors, and catalysts, are expected to increase in industrial use. This will 
subsequently lead to additional occupational exposures, making toxicology screenings crucial. 
Previous toxicology studies have presented conflicting results as to the extent of CeO2 toxicity, 
which is hypothesized to be due to the ability of Ce to exist in both a +3 and +4 valence state.  
Thus, to study whether valence state and oxygen vacancy concentration are important in CeO2 
toxicity, CeO2 nanoparticles were doped with gadolinium to adjust the cation (Ce, Gd) and anion 
(O) defect states. The hypothesis that doping would increase toxicity and decrease antioxidant 
abilities as a result of increased oxygen vacancies and inhibition of +3 to +4 transition was 
tested. Differences in toxicity and reactivity based on valence state were determined in RLE-6TN 
rat alveolar epithelial and NR8383 rat alveolar macrophage cells using enhanced dark field 
microscopy, electron paramagnetic resonance (EPR), and annexin V/ propidium iodide cell 
viability stain. Results from EPR indicated that as doping increased, antioxidant potential 
decreased. Alternatively, doping had no effect on toxicity at 24 hours. The present results imply 




 ratio, antioxidant potential 
decreases, suggesting that differences in reactivity of CeO2 are due to the ability of Ce to 
transition between the two valence states and the presence of increased oxygen vacancies, rather 
than dependent on a specific valence state. 
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Introduction 
Cerium oxide (CeO2) nanoparticles are useful in a variety of applications, including 
polishing agents, solar cells, and catalysts; they have also found use as a diesel fuel additive 
[120, 121]. Cerium (Ce), a rare earth metal of the lanthanide series, is the most abundant rare 
earth metal making research into the production and use of CeO2 nanoparticles desirable. When 
in the form of CeO2, the Ce atom can exist in both a trivalent (Ce
3+
) and more stable tetravalent 
(Ce
4+
) state, allowing the nanoparticles to store and release oxygen [122]. This ability has 
increased industrial interest into CeO2 and its potential use in catalysts [85]. In fact, production 
of CeO2 with increased oxygen storage and releasing properties is desirable in industry to 
increase its catalytic properties. This increased interest will result in growth in the industrial uses 
of CeO2 and consequently result in greater exposure risks, specifically inhalation risks, for 
individuals working in the manufacturing process.  Therefore, to understand and limit potentially 
toxic inhalation exposures, investigation into the toxicity of CeO2 is crucial.  
 Studies of the toxicity of this nanomaterial have been completed using various cell types, 
including pulmonary epithelial cells, macrophages, lung fibroblasts, and endothelial cells, but 
there have been conflicting results. For example, in pulmonary epithelial cells (BEAS-2B and 
A549 cells), CeO2 can either exert toxicity mediated by reactive oxygen species (ROS) 
production [87, 88] and Nrf-2 signaling [123] or has antioxidant-like properties [93]. 
Additionally, CeO2 has antioxidant-like properties under induced oxidative stress in RAW 264.7 
macrophage cells [93] and protective effects against induced apoptosis in U937 and Jurkat 
lymphocyte cells [83]. These conflicting findings have been hypothesized to be a result of the 




 valence states and the subsequent oxygen 




 is thought to 
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generate superoxide anions, which can produce damaging hydroxyl radicals. It is also postulated 
that Ce
3+
 can react with hydroxyl radicals and act as an antioxidant [82, 83, 88, 124]. Thus, it is 
possible that the valence state of Ce affects whether CeO2 nanoparticles play a protective or toxic 
role in exposed cells. Based on previous research, we hypothesize valence state determines the 
extent of CeO2 toxicity and that when CeO2 exist in a greater 3+/4+ ratio, it’s toxicity will 
increase and antioxidant potential will decrease. To test this hypothesis and assess the effects of 
valence state, a technique known as doping was employed. Doping is the process of intentionally 
introducing impurities into a pure substance to modulate electrical properties. To modulate the 
oxygen storage and release capacity of CeO2 nanoparticles, rare earth metals ions with low 
valence states are typically used [85]. For this study, gadolinium (III) oxide (Gd2O3) was used to 
produce increased oxygen vacancies in the CeO2 nanoparticle lattice [85] and force the valence 
state toward a greater +3/+4 ratio. Two types of doped CeO2 nanoparticles were prepared and 
used for this study, a 10mol% and 20mol% Gd in CeO2. In addition, pure CeO2 nanoparticles 
were tested. Previous studies have shown that Gd2O3 itself exhibits toxicity [125], therefore 
Gd2O3 controls were used throughout the study to ensure any differing effects between cerium 
compounds were due to valence state and transitional ability rather than the presence of Gd2O3. 
The effect of valence state and transitional ability of pure CeO2 nanoparticles and doped CeO2 
nanoparticles on ROS and toxicity was assessed. 
   
Materials and Methods 
Cell culture 
RLE-6TN rat alveolar type II cells (ATCC; Rockville, MD) were cultured following a modified 
ATCC recommended protocol. Cells were cultured in Ham’s F12 medium with 5% fetal bovine 
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serum, and 50 mg/ml penicillin/streptomycin (Thermo Scientific; Pittsburgh, PA). Cells were 
grown at 37°
 
C in a 5% CO2 incubator and were passaged following trypsinization. RLE-6TN 
cells were chosen for these studies to represent the pulmonary alveolar region most likely to 
come into contact with nanoparticles. NR8383 rat macrophage cells (ATCC; Rockville, MD) 
were cultured following the ATCC recommended protocol. Cells were cultured in Ham’s F12K 





C in a 5% CO2 incubator and were passaged by transferring floating cells to culture flasks.  
 
Immunocytochemistry staining of RLE-6TN cells 
Because alveolar type II cells act as the progenitor cells for alveolar type I cells in the pulmonary 
environment [126], immunocytochemistry (ICC) staining was completed to determine the 
phenotype of the cultured cells throughout the experiments. Briefly, cells were plated on 
autoclaved glass coverslips in 12 well plates at 1 x 10
5 
/ well and grown until 80% confluent. 
Media was the removed, cells were washed with PBS, then fixed with 3.7% formaldehyde for 15 
minutes. Cells were washed twice with cold PBS and immunofluorescence was carried out using 
primary antibodies against P180 (1:100, Abcam; Cambridge, MA) and Purinergic receptor P2X 
ligand-gated ion channel 7 (P2RX7) (1:200, Abcam; Cambridge, MA), and secondary Alexa 488 
and 568 antibody conjugates (1:200, Invitrogen; Grand Island NY). Coverslips were mounted 
onto slides with Fluoromount G (eBioscience; San Diego, CA) and cells were imaged using an 
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CeO2 Nanoparticle Production and Characterization 
Nanoparticle production and characterization were completed by Dr. Edward Sabolsky, Dr. 
Rajalekshmi Pillai, Ms. Kelly Pisane, and Dr. Aleksandr Stefaniak. Gd-doped CeO2 nano powder 





) of cerium (IV) ammonium nitrate (Ce(NH4)2(NO3)6, 99.9% 
purity) and gadolinium nitrate hexa-hydrate (Gd(NO3)3∙6H2O) were prepared by dissolving the 
salts into deionized water at room temperature. The as-prepared solutions were mixed together 
under vigorous stirring. An aqueous solution of tetramethyl ammonium hydroxide (TMAH) was 
added drop by drop until the pH of the solution reached 10. After 30 minutes of stirring, a white 
or yellowish gel-like precipitate was formed and settled rapidly. The supernatant of the solution 
was decanted and the resulting solid was rinsed several times with deionized water and 
hydrothermally treated at 240°C for 1 hour under autogenous pressure without stirring to obtain 
cerium (or Gd-doped cerium) oxide. The clear supernatant was decanted and the yellowish 
precipitate was washed with isopropanol and then dried at 80-85°C overnight.  
An X’PERT PRO Panalytical X-ray diffractometer (Westborough, MA) was used to 
determine the phase of the prepared ceria powders using Cu Kα radiation. Data was collected 
from 10°-90° angles (2θ) with a step size of 0.02 increments at a rate of 1°/minutes. Phase 
identification was achieved by X’PERT PRO software through the comparison of indexed 
powder diffraction files maintained by International Center for Diffraction Data. The 
morphology of the synthesized ceria powders was examined by scanning electron microscopy 
(SEM; JEOL 7600F; Peabody, MA). Energy-dispersive X-ray spectroscopy (EDS) was used to 
identify the elemental composition of the prepared powders. The X-ray photoelectron 
spectroscopy (XPS) measurements were carried out using a Physical Electronics, PHI 5000 
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Versa Probe (XPS/UPS) spectrometer (Chanhassen, MN) with a monochromatic Al Kα source 
operated at 300 W and a base pressure of 5 x 10
-8
 Torr. XPS is a surface sensitive technique that 
analyzes the top 25 to 50 angstroms of a particles exterior. The spectrometer was configured to 
operate at high resolution with energy of 100 eV. The acquisition time of the sample was kept 
low to minimize surface oxidation state changes during X-ray irradiation. The XPS analysis was 
performed to understand the changes in the valence state and binding energy of the constituent 
elements on powder surfaces. The work function of the instrument was calibrated to a binding 
energy of 83.96 eV for the Au 4f7/2 line for metallic gold, and the dispersion of the spectrometer 
was adjusted to a binding energy of 932.62 eV. The powder samples were placed on the sample 
holder using a double-side conductive tape followed by 6 hour evacuation prior to analyses. 
Survey spectra were collected by 1.0 eV steps at analyzer pass energy of 160 eV and the high 
resolution analysis of small spectrum regions by 0.05 eV steps and pass energy of 20 eV. The 
integrated area under the curve of each de-convoluted peak was used to calculate the 
concentration of Ce
3+







Ce 00  where Ai is the integrated area for 
peak “i”.  
The size distributions of CeO2 and Gd-doped CeO2 nanoparticles in a suspended state 
were assessed using dynamic light scattering (DLS). DLS analyzes the velocity distribution of 
suspended particles by detecting fluctuations of scattered light produced by Brownian motion of 
the particles and provides hydrodynamic radius or diameter of the particles. All measurements 
were performed using a Nano ZS90 instrument (Malvern Instruments; Worcestershire, UK).  
Prior to measurement, each sample cell was cleaned, rinsed with 0.02 µm-filtered water, and pre-
wetted with dispersion media (DM).  Suspensions of each material in DM was subjected to 
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ultrasonic agitation using a probe tip for 10 to 20 minutes (delivered energy = 4500 to 9000 J) 
until a uniform dispersion appeared.  An ice bath was used to cool the samples during sonication. 
The zeta potentials of CeO2 and Gd-doped CeO2 nanoparticles in a suspended state were 
assessed to describe the stability of the dispersions in DM. All measurements were performed 
using a Nano ZS90 instrument (Malvern Instruments; Worcestershire, UK).  Prior to 
measurement, each sample cell was cleaned and rinsed with 0.02 µm-filtered water and ethanol.  
All dispersant media were filtered through a 0.02 µm membrane prior to use as well.  The 
viscosity of the dispersant was determined at room temperature using a VS-10 viscometer 
(Malvern Instruments) and measured values were used in the calculation of zeta potential.  Each 
nanoparticle suspension was subjected to ultrasonic agitation for up to 10 minutes using a probe 
tip (delivered energy = 4400 J).  The Smoluchowski approximation of 1.5 was used for Henry’s 
function and a pH of 7.51 was determined for the DM.   
Nitrogen gas adsorption was used to determine powder-specific surface area (SSA) using 
a multipoint Brunauer, Emmett, and Teller (BET) instrument (ASAP2020 surface area analyzer; 
Micromeritics; Norcross, GA).  Prior to analysis, powders were outgassed under vacuum (0.013 
torr) for 3 hours at 150° C to remove moisture [128].  The transmission electron microscopy 
(TEM) samples were prepared by sonicating a mixture of CeO2 nanopowder and DM for 2 
minutes to disperse the nanoparticles.  Ethanol was added and the solution was sonicated for an 
additional 5 minutes.  One drop of the resulting solution was placed on a carbon coated copper 
TEM grid for imaging on a JEOL JEM 2100 (Peabody, MA) TEM with a LaB6 filament operated 
at 200 kV.  Regular micrographs were taken with a Gatan ES500W (Gatan; Pleasanton, CA) 
digital camera and high resolution images were obtained with an Orius SC1000 (Gatan; 
Pleasanton, CA) camera. 
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Determination of cellular interaction 
To visualize nanoparticles, which are not visible using typical light microscopy, enhanced 
darkfield microscopy was employed [100]. RLE-6TN and NR8383 cells were grown on cleaned, 
autoclaved cover-glass (Chemglass Life Sciences; Vineland, NJ) until 60-80% confluent. CeO2, 
Gd-doped CeO2, and Gd2O3 nanoparticles were prepared in DM at a stock concentration of 1 
mg/ml, as previously described [99]. Cells were then treated with CeO2 or Gd2O3 (Sigma-
Aldrich; St. Louis, MO) nanoparticles at a final concentration of 10 µg/ml for 5 minutes, 1 hour, 
and 3 hours. Following incubation, the medium was removed and the cells were washed 3 times 
with warm phosphate buffered saline (PBS), fixed with 10% formalin for 10 minutes, washed 
three times with PBS, mounted with Fluoromount G (eBioscience; San Diego, CA), and sealed 
with clear nail polish. Slides used for this experiment were purchased as clean cut slides to avoid 
silica particle residue, which results in high background during imaging (Schott Nexterion, 
Arlington, VA). Following mounting, images were acquired at 60x magnification using a 
Cytoviva enhanced darkfield microscopy system (Aetos Technologies; Inc., Auburn, AL) 
integrated into an Olympus BX41 upright optical microscope equipped with an Olympus DP73 
digital camera (Olympus; Center Valley, PA).  
 
Electron Paramagnetic Resonance (EPR) 
A spin trap technique was used to form long-lived free radicals that could be detected by EPR 
through addition of DEPMPO (5-(diethioxyphosphoyl)-5-methyl-1-pyrroline N-oxide) or DMPO 
(5,5’-dimethylpyrroline N-oxide). EPR measurements were collected using a flat cell assembly 
and Brüker EMX spectrometer (Billerica, MA). CeO2 and Gd-doped CeO2 nanoparticles were 
incubated at a final concentration of 1 mg/ml with 50 mM DEPMPO (Cayman Chemical, Ann 
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Arbor, Michigan), 3.5 mM xanthine and 2 U/ml xanthine oxidase (Sigma Aldrich) for 3 minutes 
to produce superoxide radicals. To induce hydroxyl radicals in an acellular system and assess 
antioxidant potential, CeO2 and Gd-doped CeO2 were incubated at a final concentration of 1 
mg/ml with 100 mM DMPO (Sigma Aldrich) and1 mM H2O2, and then exposed to UV light for 
1 minute. The mass of Gd2O3 powder was adjusted to achieve a final concentration of 179 µg/ml, 
as this value represents the theoretical amount of elemental Gd in the 20mol% Gd-doped CeO2 
nanoparticles. This reaction was also run in the absence of UV light to assess the ability of CeO2 
and Gd-doped CeO2 to produce hydroxyl radicals. Samples were run in triplicate and instrument 
settings are indicated under Results. Signal intensity (peak height) was used to measure the 
relative amount of superoxide radicals produced and is measured in mm.   
 For cellular EPR, CeO2 and Gd-doped CeO2 at final concentrations of 1 mg/ml or Gd2O3 
at 179 µg/ml were incubated with either RLE-6TN or NR8383 cells at 2 x 10
6
 cells/ml and 200 
mM DMPO for 3 minutes at 37°
 
C [57, 101]. Reactions were run in triplicate. This reaction was 
repeated but 2 mM Cr (VI) was added to the system to induce hydroxyl radicals. Peak heights 
represent relative amounts of hydroxyl radicals produced and are measured in mm.  
 
Annexin V/ Propidium Iodide  
The degree of apoptosis and necrosis induced by CeO2 and Gd-doped CeO2 at 24 hours was 
determined by flow cytometry. RLE-6TN cells were seeded at 1 x 10
5
 cells per well in 24 well 
plates and NR8383 cells were seeded at 3 x 10
5
 cells per well. Following 24 hours of growth, 
cells were treated with CeO2 and Gd-doped CeO2 at a final concentration of 10 µg/ml or 50 
µg/ml for 24 hours or treated with Gd2O3 at a final concentration of 1.79 µg/ml or 8.95 µg/ml. 
The annexin V/ propidium iodide assay was completed according to company protocol 
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(Trevigen; Gaithersburg, MD). Briefly, cell media were collected followed by trypsinization of 
cells for 2 minutes. Trypsinized cells were combined with media to ensure collection of viable, 
apoptotic, and necrotic cells. Following a washing step, cells were incubated for 15 minutes with 
100 µl annexin V/ propidium iodide stain then analyzed on a BD Biosciences LSR II flow 
cytometer. All data were analyzed using DIVA software and 10,000 events per sample were 
collected. Samples were run three times in duplicate and are presented in graphical rather than 
scatter plot format.  
 
Statistical Analysis 
All data are represented as the mean ± standard deviation for each condition. To compare 
responses between groups, a one-way analysis of variance (ANOVA) and Tukey post-test were 
performed using GraphPad Prism 6 software (GraphPad Software, Inc.; La Jolla, CA). Statistical 
significance is shown when p<0.05. 
 
Results 
Immunocytochemistry staining of RLE-6TN cells 
Immunocytochemistry was utilized to determine whether the RLE-6TN cells were type II or type 
I alveolar epithelial cells. Staining demonstrates that cells used for these studies were a mix of 
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CeO2 Characteristics 
The XRD diffraction peaks of the CeO2, which represent the crystalline plane (1 1 1), (2 0 0), (2 
2 0) and (3 1 1), correspond to cubic fluorite crystal structure (JCPDS Data Card # 88-2326), 
where Ce is in the 4+ oxidation state [129]. The XRD pattern of CeO2 10% Gd and CeO2 20% 
Gd showed no Gd oxide peaks, indicating the formation of Gd-CeO2 solid solution [129] (data 
not shown). SEM was used to assess the agglomeration of the nanoparticles and indicated that 
the CeO2 and doped-CeO2 powders agglomerated and that there was a wide distribution of 
particle sizes. The EDS pattern of pure CeO2 (data not shown) did not reveal any impurities 
present in the powder. 
Figure 3.3A. shows the wide scan XPS survey spectra for pure CeO2, CeO2 10% Gd, and 
CeO2 20% Gd. High resolution XPS spectra for Ce (3d), the fitted curve, and the corresponding 
de-convoluted peaks of CeO2 nanoparticles are shown in Figure 3.3B. The recorded XPS spectra 
were charge corrected with respect to the C (1s) peak at 284.6 eV. The peaks in the spectrum of 
Ce were de-convoluted using the multi pack software. The letter “v” marked in the spectra 
indicates the spin-orbit coupling 3d5/2 and the letter “u” indicates spin orbit coupling 3d3/2 of pure 
CeO2.  The peaks denoted by v0, v′, u0 and u′ represent Ce
3+
 ions whereas those marked by v, v′′, 
v′′′, u, u′′ and u′′′ represent Ce
4+
 ions. It is evident that the de-convoluted Ce (3d) spectrum is 
relatively complex due to the presence of Ce in 3+ and 4+ oxidation states as well as multiple d-
splitting. The spin orbit doublets for pure CeO2, 3d3/2 (885.3 and 903.4 eV) and 3d5/2 (881.9 and 
888.6 eV) are clearly evident for both valence states of Ce, indicating that Ce is in mixed valence 
states of 3+ and 4+ [130]. High resolution XPS spectra for Ce (3d), the fitted curve, and the 
corresponding de-convoluted peaks of pure CeO2, CeO2 10% Gd, and CeO2 20% Gd are 
presented in Figure 3.3. Table 3.1 shows the binding energies, peak heights, peak areas and the 






atoms of pure CeO2, CeO2 10% Gd and CeO2 20% Gd. The 
characteristic peaks of Gd
3+ 
3d5/2 was observed in the region 1183.83±0.7 eV and 1215.83± 0.7 
eV in CeO2 10% Gd and 1187.07 ±0.7 eV and 1219.07 ± 0.7 eV in CeO2 20% Gd, indicating that 
Gd is in the 3+ oxidation state (Figure 3.3). It was observed that in both the peaks of Gd
3+
, there 
was a slight shift towards the lower binding energy, which can be attributed to the increase in 
valence electron density. From the table it may be seen that the addition of Gd increases the Ce
3+ 




were found to be 16.9, 42.7 and 43.9 % for pure CeO2, CeO2 10% 
Gd and CeO2 20% Gd, respectively. The high value of v0/u0 and v′/u′ indicates that nano-sized 
ceria exhibits better catalytic activity due to the  large amount of electronic and ionic defects, 




 atoms and the corresponding oxygen vacancies 
(VO

). Gd is a lanthanide that can be used to modify the chemical, crystal structure, and defect 
state of ceria.  The atomic radius and the electron negativity of Gd are close to that of the cerium 





 states within the structure increases, the structure must compensate for 
these additions by increasing the positive charge within the material to retain charge neutrality.  
The material typically compensates for this ionic defect by releasing oxygen from the structure, 
resulting in an open anionic site within the structure (oxygen vacancy, VO

).  The oxygen 
vacancies may be considered as open sites within the bulk and surface structure for the uptake of 
oxygen, and are critical for the efficient diffusion of oxygen ions within or on the surface of the 
ceria.  
Hydrodynamic diameter and zeta potential were measured to assess particle 
agglomeration under physiological exposure conditions while TEM was used to observe particle 
size. The results demonstrated that the hydrodynamic diameters of all three CeO2 nanoparticle 
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agglomerates (CeO2, 875±58; CeO2 10% Gd, 201±5; CeO2 20% Gd, 176±8) (Table 3.2) were 
larger than the observed size under TEM (~5nm) (Figure 3.4). The zeta potential shows that the 
nanoparticle dispersions are likely to agglomerate in DM (Table 3.2) based on the stability 
categories developed by Riddick [131]. Thus the results show that the stability of the 
nanoparticle dispersions is fairly poor over time. The surface area results implicate that the pure 
CeO2 and CeO2 10% Gd were of similar surface area while the surface are of CeO2 20% Gd was 
substantially less (Table 3.2). 
 
Cellular Interactions with Particles Show Accumulation Over Time 
Enhanced darkfield microscopy was used to visualize CeO2 and Gd2O3 nanoparticle cellular 
interactions over a time course of 3 hours. The results demonstrated that all CeO2 nanoparticles 
and Gd2O3 accumulated with cells over time (Figure 3.5). Figure 3.5B illustrates that all 
nanoparticles associated with NR8383 cells more rapidly than RLE-6TN cells. 
 
Super Oxide Radical Scavenging with CeO2 Nanoparticles  
Studies have demonstrated that CeO2 has superoxide dismutase properties [124], thus the effect 
of doping and alteration in valence state on superoxide scavenging was assessed using a xanthine 
oxidase/xanthine reaction and spin trap technique. Results showed that all three CeO2 
nanoparticles had significant scavenging properties in a 3 minute acellular system; however, the 




- 66 - 
 
Hydroxyl Radical Scavenging with CeO2 Nanoparticles 
As a result of the rapid association of nanoparticles with cells (within 5 minutes) and previous 
studies indicate that CeO2 can induce or scavenge ROS [123, 124, 132], superoxide and hydroxyl 
radical production was measured. To determine whether CeO2 and Gd2O3 nanoparticles are 
capable of converting H2O2 into hydroxyl radicals, acellular Fenton-like reactions were carried 
out using EPR and a spin trap method. Neither CeO2 (pure and doped) nor Gd2O3 induced 
hydroxyl radicals in an acellular system (data not shown). Further, because previous studies have 
shown CeO2 has scavenging abilities [93], the ability of CeO2 to scavenge hydroxyl radicals was 
carried out using H2O2, UV light and a spin trap method. Results showed that pure CeO2, CeO2 
10% Gd, and CeO2 20% Gd had significant antioxidant effects, while Gd2O3 had no significant 
effects on induced hydroxyl radicals within 3 minutes in an acellular system (Figure 3.7).  
 While all three CeO2 nanoparticles did not generate hydroxyl radicals in an acellular 
system, previous studies have shown that CeO2 induces significant ROS in vitro [88, 123]; thus, 
cellular EPR was completed. The results showed that in RLE-6TN cells, all three CeO2 
nanoparticles significantly reduced the presence of hydroxyl radicals; however, in NR8383 cells, 
only pure CeO2 and CeO2 10% Gd significantly scavenged the free radicals. In both cell lines, 
the Gd2O3 control had no effect (Figures 3.8 and 3.9). 
 
CeO2 Nanoparticle Exposure Effects on Cell Viability 
To measure CeO2 effects on apoptosis and necrosis at 24 hours, an annexin V/ propidium iodide 
dual stain was used. At 24 hours, no CeO2 nanoparticle affected overall cell viability in RLE-
6TN cells at either 10 µg/ml or 50 µg/ml doses. However, in the population of dead RLE-6TN 
cells, CeO2 10% Gd and CeO2 20% Gd at10 µg/ml induced significant necrosis (PI positive) 
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compared to control cells. Further, Gd2O3 induced significant apoptosis (annexin V positive) at 
8.95 µg/ml compared to the control (Figure 3.10). 
In NR8383 cells, pure CeO2, doped CeO2 and Gd2O3 nanoparticles had no significant 
effects on overall cell viability or development of necrosis. However, Gd2O3 significantly 
increased the number of cells undergoing apoptosis at a dose of 8.95 µg/ml compared to the 
control (Figure 3.11).  
 
Discussion 
As industrial interest in the use of CeO2 nanoparticles increases, so will manufacturing 
and worker exposures. While disagreements exist within the literature as to the nature of CeO2 
toxicity, it is almost universally agreed upon that CeO2 affects ROS, theoretically due to its 
exceptional redox potential. Therefore, this study focused on examining how altering the valence 
state of CeO2 nanoparticles through doping affects CeO2 toxicity, specifically its effects on ROS 
generation. 




 ratio of 
the nanoparticles (Table 3.1) [85]. XPS analysis of powder surfaces indicated that doping with 




, a rate that increased as the concentration 
of Gd2O3 increased. CeO2 containing 10mol% Gd2O3-doped into the nanoparticles had a ratio 
shift from 16% to 42% compared to pure CeO2, while the 20mol% Gd2O3-doped nanoparticles 
shifted the ratio from 16% to 44%. Alternatively, a study completed by Celado et al., showed 
that doping with samarium (Sm) decreased the amount of Ce
3+
 in the nanoparticles [83]. This 
difference in doping outcome may be a result of Gd2O3 to introduce more Ce
3+
 oxidation state 
into the nanoparticle compared to Sm as previously shown [133]. While the effects of doping 
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observed in the two studies conflict, our results correlate with the general finding that as doping 
increases, antioxidant potential decreases. Thus, in conjunction with the works of Celado et al., it 




 is not as crucial in determining antioxidant potential of CeO2 
nanoparticles as is the ability of Ce to transition between the two valence states. This transitional 
ability is hindered following doping since the Ce nanoparticles are forced toward one valence 
state, and due to the stability of Gd in the lattice structure, unable to transition as easily to the 
other state [85].  This decreased antioxidant effect was most notable in the cellular EPR model, 
where CeO2 20% Gd was significantly different in its scavenging abilities when compared to the 
pure CeO2 and CeO2 10% Gd (Figures 3.8 and 3.9). Differences in scavenging ability also 
existed between the two cell lines; specifically, CeO2 20% Gd  had no significant effect on 
induced free radicals in NR8383 cells whereas it was able to significantly reduce hydroxyl 
radical formation in RLE-6TN cells. While this was unexpected, discrepancies between cell lines 
are not unusual, especially in CeO2 nanoparticle toxicity studies, and may be the result of 
differences in cellular physiology and function [88, 134]. Thus, in these studies it appears that 
CeO2 is a less efficient antioxidant in NR8383 cells and that doping has a more pronounced 
effect on responses of macrophages than those of epithelial cells. The Gd2O3 had no significant 
effects on ROS in either EPR model, implying that the antioxidant abilities of the CeO2 are due 




, or oxygen vacancies, and not the dopant.  
 To ensure that differences in cellular-reactivity were not due to differences in association 
between the particles and the cells, enhanced dark field microscopy was utilized. All of the 
nanoparticles were capable of associating with both cell types in a matter of minutes (Figure 
3.5), suggesting that the cells would be capable of responding in the short time course conducted 
in EPR studies, and further, that measured EPR differences were not due to differences in 
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cellular association. These results were anticipated based on zeta-potential (Table 3.2), and 
imply that the presence of Gd did not alter important surface chemistry necessary for interaction 
of CeO2 with cells. Increased concentrations of Gd also did not alter the observed size of the 
nanoparticles (data not shown), implying that differences in reactivity are not a result of 
differences in size. The hydrodynamic diameters of the CeO2 10% Gd and CeO2 20% Gd 
particles in DM were smaller than the pure CeO2; this difference in hydrodynamic size compared 
to measured size from SEM is attributed to the sonication of the particle suspensions prior to 
DLS measurement. Agglomeration is central in nanoparticle-cellular interactions and reactivity 
[135] and may therefore be important  in differences in antioxidant potential; however, 
differences in toxicity did not exists between the particles as would be expected if agglomeration 
were important in determining reactivity. This suggests that the differences in antioxidant 
abilities are due to valence state and transitional ability rather than variances in nanoparticle 
agglomeration. 
 None of the three CeO2 nanoparticles induced significant changes in overall cell viability 
and did not induce apoptosis or necrosis at 24 hours (Figures 3.10 and 3.11). While the lack of 
differences between the CeO2 nanoparticles was unexpected, numerous studies have shown a 
lack of CeO2 reactivity at similar doses [83, 89] and have accounted this non-toxic effect to CeO2 
transitional ability and presence of Ce
3+/4+
. In agreement, Celardo et al., [83] also reported that 
doping had no effect on cellular viability, again implying that changes in viability measured in 
other CeO2 nanoparticle studies is not likely a result of valence state.  
To further elucidate the effect of Gd2O3 on differences in CeO2 toxicity, annexin V/ PI 
dual staining was completed and implied that at a concentration equivalent to the quantity of 
Gd2O3 in the 50 µg/ml dose of CeO2 20% Gd, the pure Gd2O3 caused significant apoptosis at 24 
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hours in both cell lines (Figures 3.10 and 3.11). In fact, all three CeO2 nanoparticles did not 
elicit apoptosis. This implies that Gd did not separate from the doped nanoparticles and interact 
with the cells to yield the observed effects.   
Previous studies have suggested that the valence state of Ce in CeO2 nanoparticles is 
important in toxicity and ROS production [82, 122]; however, attempts to elucidate which 
valence state is important for biological effects are lacking. This study attempted to confirm, 
through alterations in CeO2 valence state ratio, a specific valence state is a less important 
determinant of CeO2 reactivity than the presence of mixed valence state and transitional ability. 
Overall our initial findings suggest that doping does not increase toxicity but appears to inhibit 
CeO2 antioxidant potential in a rapid cellular exposure in support of our hypothesis. Since CeO2 
toxicity results greatly differ between in vitro and in vivo models [39, 82, 90, 136], further 
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Table 3.2. Characteristic data of pure and doped CeO2 nanoparticles. 
 






   
Surface Area  
CeO2 
 
875 ± 58 
 
-10.6 ± 2.4     204.8 ± 14.6 
CeO2 10% Gd 
 
201 ± 5 
 
-16.3 ± 2.6     225.4 ± 34.1 
CeO2 20% Gd 
 
176 ± 8 
 






























Figure 2. Immunocytochemistry staining of RLE-6TN cells. RLE-6TN cells were grown on 
coverslips until 80 % confluent, then fixed and stained with antibodies against P180 (Red) and 
P2RX7 (Green). Coverslips were mounted on slides with Fluoromount G (Dapi) and sealed with 












Figure 3.3. XPS survey of CeO2 nanoparticles. A. Wide-scan XPS survey scan spectrum of 
CeO2 20% Gd, CeO2 10% Gd, and pure CeO2. B. High resolution XPS spectrum of CeO2 20% 



























Figure 3.5. Epithelial and macrophage cells associate with CeO2 nanoparticles over a time 
course. A CytoViva enhanced dark-field microscopy system provides images of high-contrast 
CeO2 nanoparticles (bright spots) against a dark background of cells. Cells were exposed to 
CeO2 nanoparticles for 5 minutes, 1 hour, or 3 hours. A. Representative images of RLE-6TN 
cells associated with CeO2 nanoparticles. B. As in A., except images are representative of 
NR8383 cells. Scale bar, 5 µm. 
 
 






Figure 3.6. CeO2 nanoparticles reduce superoxide radicals. A. CeO2 nanoparticles at 1 mg/ml 
(Gd2O3 at 179 µg/ml) were combined with50 mM DEPMPO, 3.5 mM xanthine and 2 U/ml 
xanthine oxidase (XO/X) for 3 minutes. EPR setting were: center field, 3490 G; scan width, 200 
G; time constant, 0.41s; modulation amplitude, 1 G; receiver gain, 2.5 x 10
4
; frequency, 9.8 
GHz; and power, 63 mW. Representative spectra for each sample are shown. B. The first, fourth, 
fifth and eighth peaks were used for measurement of superoxide radical production. Signal 
intensity was measured in millimeters. Error bars represent the mean ± standard deviation. *, p 
<0.05 compared to XO/X. 
 
 






Figure 3.7. CeO2 nanoparticles reduce hydroxyl radicals. A. CeO2 nanoparticles at 1 mg/ml 
(Gd2O3 at 179 µg/ml) were combined with 100 mM DMPO and1 mM H2O2 then exposed to UV 
light for 1 minute. EPR setting were: center field, 3487 G; scan width, 100 G; time constant, 
0.41s; modulation amplitude, 1 G; receiver gain, 2.5 x 10
4
; frequency, 9.8 GHz; and power, 63 
mW. Representative spectra for each sample are shown. B. The second and third peaks were 
used for measurement of hydroxyl radical production. Signal intensity was measured in 









Figure 3.8. CeO2 nanoparticles reduce induced hydroxyl radicals in RLE-6TN cells. A. 
CeO2 nanoparticles at 1 mg/ml (Gd2O3 at 179 µg/ml) were combined with 200 mM DMPO and 
2x10
6
 cells/ml then incubated for 3 minutes at 37
o
C. EPR setting were: center field, 3495 G; scan 
width, 100 G; time constant, 0.41s; modulation amplitude, 1 G; receiver gain, 6.3 x 10
2
; 
frequency, 9.8 GHz; and power, 126 mW. Representative spectra for each sample are shown. B. 
The second and third peaks were used for measurement of hydroxyl radical production. Signal 
intensity was measured in millimeters. Error bars represent the mean ± standard deviation. *, p 









Figure 3.9. CeO2 nanoparticles reduce induced hydroxyl radicals in NR8383 cells. A. CeO2 
nanoparticles at 1 mg/ml (Gd2O3 at 179 µg/ml) were combined with 200 mM DMPO and 2x10
6
 
cells/ml then incubated for 3 minutes at 37
o
C. EPR setting were: center field, 3495 G; scan 
width, 100 G; time constant, 0.41s; modulation amplitude, 1 G; receiver gain, 6.3 x 10
2
; 
frequency, 9.8 GHz; and power, 126 mW. Representative spectra for each sample are shown. B. 
The second and third peaks were used for measurement of hydroxyl radical production. Signal 
intensity was measured in millimeters. Error bars represent the mean ± standard deviation. *, p 









Figure 3.10. CeO2 nanoparticles cause no significant changes in RLE-6TN cell viability at 
24 hours. A. RLE-6TN cells were exposed to CeO2 at 10 µg/ml or 50 µg/ml for 24 hours (Gd2O3 
at 1.79 µg/ml or 8.95 µg/ml). Collected cells were incubated with annexin V/ propidium iodide 
on ice for 15 minutes then run and 10,000 events were measured. Graph represents cells that 
were viable after 24 hours. ZnO and CuOx, at 50 µg/ml, were used as positive controls for 
apoptosis and necrosis respectively and DM was used as a negative control. Error bars represent 
mean ± standard deviation. *, p <0.05 compared to control. B. Cells stained positive for annexin 
V. C. Cells stained positive for both annexin V and propidium iodide. C. Cells stained positive 
for propidium iodide. 
 
 




Figure 3.11. CeO2 nanoparticles cause no significant changes in NR8383 cell viability at 24 
hours. A. NR8383 cells were exposed to CeO2 at 10 µg/ml or 50 µg/ml for 24 hours (Gd2O3 at 
1.79 µg/ml or 8.95 µg/ml). Collected cells were incubated with annexin V/ propidium iodide on 
ice for 15 minutes then run and 10,000 events were measured. Graph represents cells that were 
viable after 24 hours. ZnO and CuOx, at 50 µg/ml, were used as positive controls for apoptosis 
and necrosis respectively and DM was used as a negative control. Error bars represent mean ± 
standard deviation. *, p <0.05 compared to control, %, p <0.05 compared to 50 µg/ml, $, p <0.05 
compared to Gd2O3 at equivalent dose. B. Cells stained positive for annexin V. C. Cells stained 
positive for both annexin V and propidium iodide. D. Cells stained positive for propidium iodide. 
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Abstract 
Cerium (Ce), a member of the lanthanide series, is becoming a popular metal oxide for 
use in mechanical engineering. When in the form of cerium oxide (CeO2), Ce can exist in both a 
3+ and 4+ valence state. This makes the particle an ideal catalyst as a result of improved oxygen 
storage and releasing capacity. For this reason, an increase in the number of consumer products 
containing CeO2 nanoparticles is expected; thus, understanding the potential toxicity of CeO2 
nanoparticles during manufacturing is crucial. Previous in vitro and in vivo evidence has 
demonstrated that CeO2 has either antioxidant or oxidant-like properties, which is postulated to 
be due to the nanoparticles ability to transition between 3+ and 4+ valence states. Therefore, we 
chose to chemically modify the nanoparticles through doping in order to shift the valence state 
toward 3+. Pure CeO2 and two doped nanoparticles, 10 mol% gadolinium (Gd) and 20 mol% Gd, 
were used for this study. Preliminary characteristics indicated that doping results in minimal size 
and zeta potential changes but drastic changes in valence state. Following characterization of the 
nanoparticles, male, Sprague-Dawley rats were exposed to 0.5 and 1.0 mg/kg nanoparticles via 
intratracheal instillation. Animals were sacrificed, bronchoalveolar lavage fluid was collected 
and lung sections were prepared, to determine the effect of valence state on toxicity 1, 7, or 84 
days post-exposure. Preliminary results demonstrate that damage, as measured by elevation in 
lactate dehydrogenase, occurred within 1 day post-exposure and was sustained 7 days post-
exposure, but subsided to control animal levels 84 days post-exposure. Further, no inflammatory 
signaling or lipid peroxidation occurred following exposure to any of the nanoparticles. Thus, 
our results implicate that valence state has a minimal effect on CeO2 nanoparticle toxicity in 
vivo.  
Key words: Cerium oxide, nanoparticles, nanotoxicity, intratracheal instillation, valence state 
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Introduction 
Ce, the most abundant rare earth metal and a member of the lanthanide series, has been 
implicated in Ce pneumoconiosis, a restrictive lung disease characterized by severe pulmonary 
fibrosis and emphysema [137, 138]. Ce-containing rare earth metal dusts, which are used in 
industry for glass polishing and photoengraving have been associated with severe fibrosis and 
extensive Ce particle accumulation following medical examination of industry workers. In fact, 
studies have shown Ce remains within workers’ lungs for more than 20 years [139]. Thus, the 
production of new materials containing Ce, such as cerium oxide (CeO2) nanoparticles, 
necessitates toxicity studies to evaluate potential worker exposure risks and determine ways to 
improve the safety of Ce-containing products while furthering their use in industry. Previous 
studies have been completed in vitro and in vivo to determine the potential toxic effects of CeO2 
nanoparticles as a means to prevent future human health hazards; however, to date, the literature 
on CeO2 nanoparticle toxicity is conflicted. Due to the variety of uses for CeO2 nanoparticles, 
including use in catalysts, solar cells, and gas sensors, as well as use as a diesel fuel additive to 
reduce emissions and increase engine efficiency [120], toxicity screenings of this nanomaterial 
and determination of CeO2 pulmonary effects is essential. 
Previous in vitro studies of CeO2 nanoparticle toxicity have shown conflicting toxicity 
results. For example, studies completed in immune cells have reported CeO2 protects against 
induced apoptosis in U937 cells [83] or acts as an antioxidant under conditions of induced 
oxidative stress in RAW 264.7 cells [93]. Further, studies conducted in colon cells, indicate 
CeO2 nanoparticles were capable of preventing radiation induced damage through antioxidant-
like properties [136]. Conversely, studies completed in various epithelial cell lines, have 
implicated that CeO2 either exerts toxicity through ROS production [87, 88, 123] or elicits only 
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mild ROS and has antioxidant like properties [93]. These results imply that CeO2 toxicity varies 
between cell type and within similar cell types. The conflicting in vitro data is theorized to be a 
result of the ability of Ce to easily transition between 3+ and 4+ valence states [82]. When Ce is 
in the 3+ valence state, it is hypothesized that it has antioxidant potential, while in the 4+ valence 
state it produces free radicals and causes oxidative damage [82, 83, 88]. To assess the importance 
of valence state in determining CeO2 reactivity and toxicity, a technique known as doping was 
employed to modulate the electrical properties of the nanoparticles and force them toward a 
greater 3+/4+ ratio using gadolinium (III) oxide (Gd2O3) [85]. Two doped CeO2 nanoparticles 
were prepared and used for this study, a 10 and 20 mol% Gd in CeO2. Pure, unaltered CeO2 
nanoparticles were also tested in addition to a Gd2O3 control to ensure any effects seen between 
compounds were due to valence state and oxygen vacancies rather than the presence of Gd2O3 
[140]. Initial tests were conducted in vitro to determine valence state effects in both RLE-6TN 
alveolar epithelial and NR8383 alveolar macrophage rat cells [141]. Preliminary in vitro studies, 
showed valence state had no effect on toxicity, but as doping increased, the antioxidant potential 
of the nanoparticles decreased [124]. However, due to the lack of differences seen between 
nanoparticles reactivity, in vivo studies were required to understand if altering valence state 
affects CeO2 pulmonary toxicity.  
 While previous studies have been conducted to determine the toxicity of CeO2 
nanoparticles following deposition in the lungs of rats, this is the first study to chemically alter 
the valence state of the nanoparticles and assess changes in reactivity. In vivo studies have shown 
that CeO2 nanoparticles cause substantial pulmonary damage, induce inflammation, and initiate 
fibrosis at a range of doses using a variety of exposure methods, including intratracheal (IT) 
instillation and inhalation. For example, at doses ranging from 0.15 mg/kg to 7 mg/kg, rats 
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presented with markers of fibrosis within 28 days post-IT exposure [40]. A study that exposed 
rats to CeO2 nanoparticles via mouth/nose inhalation showed similar toxicity results and 
inflammatory cytokine activation, also presented data that CeO2 significantly increased reactive 
oxygen species (ROS) production and disrupted antioxidant system. This change in ROS was not 
detected in comparable in vivo studies [89, 90]. Based on these discrepancies, both within in vivo 
and in vitro systems as well as between the two models, understanding how valence state may 
affect CeO2 toxicity is imperative to ensure safe use in manufacturing.   
 To determine the effect of valence state and oxygen vacancies on CeO2 reactivity in vivo, 
Sprague Dawley rats were exposed to pure CeO2, 10 mol% Gd, or 20 mol% Gd nanoparticles via 
IT. Rats were sacrificed 1, 7, or 84 days post-one time nanoparticle exposure and overall 
pulmonary toxicity, ROS, inflammation, and pulmonary changes were assessed.  
 
Materials and Methods 
 
CeO2 Nanoparticle Production and Characterization 
CeO2 nanoparticle production and characterization was completed by Dr. Ed Sabolsky and Dr. 
Aleks Stefaniak. Gd-doped CeO2 nanopowder was prepared as previously described [141]. 
Briefly, a hydrothermal method was used in which cerium (IV) ammonium nitrate and 
gadolinium nitrate hexa-hydrate were dissolved in deionized water and mixed together. 
Tetramethyl ammonium hydroxide was added to the mixture until the pH reached 10, followed 
by precipitate formation. The precipitate was washed and hydrothermally treated at 240 °C for 1 
hour to obtain the final nanoparticles.  
 To determine the relative size of the nanoparticles in phosphate buffered saline (PBS), 
dynamic light scattering (DLS) was performed using a Nano ZS90 instrument (Malvern 
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Instrument; Worcestershire, UK). Prior to sample measurement, sample cells were cleaned, 
rinsed, and pre-wetted with PBS. Samples were exposed to ultrasonic agitation for 10 minutes 
using a probe tip to produce a uniform dispersion. 
 Zeta potential of CeO2 and Gd-doped CeO2 nanoparticles in PBS were determined using 
a Nano ZS90 instrument (Malver Instruments; Worcestershire, UK). The viscosity of the PBS 
was determined at room temperature using a VS-10 viscometer (Malvern Instruments) for use in 
determining zeta potential. Each nanoparticle suspension was sonicated for 10 minutes using a 
probe tip to produce a uniform dispersion. The Smoluchowski approximation of 1.5 was used for 
Henry’s function and a pH of 7.5 was determined for the PBS.  
 
Animal Exposures 
Animal IT exposures were completed by Mr. Mark Barger. Male Sprague-Dawley (Hla: SD-
CVF) rats (6 weeks old) were purchased from Hilltop Laboratories (Scottsdale, PA) and housed 
in an animal facility accredited by the American Association for Accreditation of Laboratory 
Animal Care in duplicate in cages individually ventilated with HEPA-filtered air. All animals 
were exposed and euthanized according to a National Occupational Institute for Occupational 
Safety and Health approved protocol that complied with the Guidelines for the Care and Use of 
Laboratory Animals. Following a one week acclimation period, rats were anesthetized with 40 
mg/kg sodium methohexital (Brevital, Eli Lily and Co.; Indianapolis IN) weighed, and placed on 
an inclined restraint board. CeO2 nanoparticles, both pure and doped, were exposed to ultrasonic 
agitation for 5 minutes prior to animal exposure. Nanoparticles were administered via 
intratracheal instillation at a final concentration of 0.5 mg/kg BW or 1.0 mg/kg BW. PBS was 
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administered by intratracheal instillation to control rats. At least 6 animals were treated per group 
and sacrificed at 1, 7, or 84 days post-exposure.  
Because CeO2 nanoparticle exposure does not have a set permissible exposure limit 
(PEL), animal dosages were selected based on other in vivo studies [39]. Importantly, the doses 
of 0.5 mg/kg and 1 mg/kg represent levels well below PEL levels for nuisance dusts, which CeO2 
would be categorized as until a PEL is set for the nanomaterial. In fact, the dosages represent a 
3.1 (high dose) or 6.2 (low dose) year worker exposure based on the PEL of 5 mg/m
3
 for 
nuisance dusts and deposition rate of 0.8 [142].  
 
Bronchoalveolar lavage  
At 1, 7, and 84 (n=6-7/treatment group) days post-exposure, bronchoalveolar lavage (BAL) was 
performed to assess lung injury and inflammation. Animals were deeply anesthetized with 
sodium pentobarbital (>100 mg/kg) and exsanguinated by cutting the abdominal aorta. The lungs 




-free PBS, pH 7.4.The lungs were further lavaged with  
aliquots of 8mls PBS until 40 mL were collected. Lavages were centrifuged at 3000 x g for 10 
minutes at 4°C. Supernatant from the first lavage was collected for lactate dehydrogenase (LDH) 
and cytokine analysis, while the supernatant from the second lavage was discarded. Cell pellets 
were then re-suspended in 1 ml PBS and evaluated as described below.  
 
Cellular evaluation 
Total cells numbers were determined using a Beckman Coulter Multisizer 4 Analyzer (Beckman 
Coulter; Indianapolis, IN). Further, amounts of polymorphonuclear leukocytes (PMN) and 
alveolar macrophages (AM) were also determined. Cells were differentiated using a Cytospin 4 
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centrifuge (Shandon Life Sciences International; Cheshire, England). Briefly, cell suspensions 
(2x10
5
) were spun for 5 minutes at 800 rpm and pelleted onto a slide. 200 cells/rat were then 
counted following staining with modified Wright-Giemsa stain and the relative abundance of 
lung AMs, PMNs, lymphocytes, and eosinophils were determined.  
 
Lactate dehydrogenase (LDH), chemiluminescence (CL), and Electron Paramagnetic Resonance 
(EPR) 
LDH measurements were collected by Dr. Melissa Badding, CL measurements were collected by 
Ms. Anna Morris, and ESR was completed by Dr. Stephen Leonard. Acellular LDH activity from 
the first BAL fluid was measured to determine general cell damage and toxicity using a COBAS 
C111 analyzer (Roche Diagnostic Systems; Montclair, NJ). Luminol-dependent CL was 
completed using cells from the second BAL. CL is a measurement of ROS formation, 
specifically a measurement of macrophage activity, which was monitored using a Berthold 
LB953 Luminometer (Berthold; Wildbad, Germany). BAL cell (1x10
6 
AM/ml) luminescence 
was measured prior and following zymosan (2mg/ml; Sigma Chemical Company; St Louis, MO) 
stimulation. Zymosan was used for its ability to stimulate and be readily engulfed by activated 
phagocytic cells [143]. Results are presented as Zymosan-stimulated minus unstimulated cell CL 
production.  
A 5, 5’dimethylpryrroline N-oxide (DMPO) spin trap technique was implemented to 
form long-lived free radicals that could be detected via EPR to assess the reactivity of the cells 
from the second lavage. EPR measurements were collected using a flat cell assembly and Bruker 
EMX spectrometer (Billerica, MA). Second BAL cells (1x10
6
 AM/ml) were combined with 200 
mM DMPO (Sigma Aldrich), and 2 mM Cr (VI) for 3 minutes at 37°C prior to hydroxyl radical 
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measurement. Instrument settings are indicated in the legend for Figure 4.3. Signal intensity 
(peak height) was used to measure the relative amount of superoxide radicals produced and is 
measured in millimeters. All data is presented as peak height fold change above control animal 
AM response to Cr (VI) 
 
Lipid peroxidation measurements (LPO) 
Following lavage, a segment of the left lung was removed from each animal and immediately 
placed at -80°C until completion of assay. LPO values were determined according to the 
manufacturer’s protocol (OxisResearch; Beverly Hills, CA) and samples were run in duplicate. 
Briefly, lung tissue (100 mg/ml) was combined with ice-cold PBS and butylated hydroxytoluene 
(50 mM), then homogenized for 30 seconds. Following homogenization, samples were 
centrifuged at 2500 g for 10 minutes at 4°C, then 200 µl of clear supernatant was removed and 
placed in a clean glass tube. After addition of kit-specific reagents and an incubation at 45°C for 
1 hour, samples were centrifuged at 2500 g for 10 minutes at room temperature and a clear 
supernatant was collected and transferred to a glass plate. Absorbance was measured at 586 nm.  
 
Cytokine measurements 
TNF-α, IL-8, and IL-6 were determined from primary BAL fluid using enzyme-linked 
immunosorbent assays (ELISAs) according to the manufacturers protocol (Life Technologies; 
Grand Island, NY) and samples were run in duplicate. Briefly, lavage fluid was added to an 
ELISA plate and incubated at room temperature for 1 to 2 hours. Following a wash step, 
biotinylated antibody was incubated for 1 hour at room temperature. The plate was washed again 
prior to the addition of the streptavidin HRP for 30 minutes at room temperature. After an 
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incubation with the TMB solution, stop solution was added to the plate and absorbance was 
measured at 450 nm minus 550 nm. 
 
Pulmonary Collagen Accumulation 
To determine the effect of CeO2 nanoparticles on collagen build-up in the lungs as a marker of 
fibrosis initiation, a Sir-Col assay (Biocolor Life Science Assays; United Kingdom) was used 
according to company protocol. Briefly, pulmonary lung tissue was homogenized using a tissue 
tearor for 30 seconds in a pepsin- (0.1 mg/ml) acid (0.5 M acetic acid) solution to help extract 
collagen from the tissue. The tissue was then incubated overnight in the solution at 4°C. 
Following incubation, 100 µl of each sample was combined with Sir-Col collagen dye and 
placed on a shaker for 30 minutes to form a collagen-dye complex. Samples were then 
centrifuged at 12,000 RPM for 10 minutes and the unbound dye was removed. Following a wash 
step with an acid-salt solution, samples were centrifuged again, and the excess liquid was 
removed. An alkali reagent was then added to the samples to solubilize the collagen dye and 100 
µl of sample was transferred to a 96 well plate. Absorbance was measured at 555 nm. 
 
Histopathological Examination 
Histopathological examination was performed on lungs, liver, and kidney sections from 84-day 
post CeO2 nanoparticle or PBS exposed animals using hematoxylin-eosin (H&E) staining on 
formalin-fixed tissues. Lung tissue was also stained with Picrosirius Red stain for detection of 
collagen fibers and fibrosis initiation. Following fixation of tissues in 10% buffered formalin, 
tissues were embedded in paraffin wax, sectioned at 5 µm, mounted on glass slides, and stained. 
Sections were examined by light microscopy by a board-certified pathologist.  
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Statistical analysis 
Data are represented as the mean ± standard error of the mean (SEM) for each condition. To 
compare responses between groups, a two-way analysis of variance (ANOVA) and Tukey 
posttest were performed using GraphPad Prism 6 software (GraphPad Software, Inc.; La Jolla, 




To determine the relative size of the nanoparticles in PBS, DLS was utilized and showed that all 
of the nanoparticles agglomerated into micron sized particles (Table 4.1). Previous data showed 
that these particles were about 5 nm as-prepared prior to suspension [141], but due to high 
surface energy of the nanoparticles they quickly agglomerate. Zeta potential results also show a 
similar trend between the nanoparticle samples, as the values fall within the Riddick category of 
delicate dispersion [131]. Further, data suggests that doping the nanoparticles drastically altered 
their valence state from 16.9% Ce
3+
 in pure CeO2 to 42.7% Ce
3+
in CeO2 10% Gd and 43.9% 
Ce
3+ 
in CeO2 20% Gd (Table 3.1). 
 
CeO2 Nanoparticles Effects on Pulmonary Cellular Influx 
To determine the effect of CeO2 nanoparticles on pulmonary cell number, total cell counts, 
macrophage counts, and PMN counts were completed on primary lavage cells. One day post-
exposure, all three nanoparticle types induced mild increases in total cells, macrophages, and 
PMNs, however these increases were not significant. By 7 days post-exposure all three 
nanoparticle types at both doses caused a significant influx of PMNs into the pulmonary 
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environment, while only the low exposure dose resulted in increased macrophage presence. By 
84 days post-exposure, all cell counts returned to normal with the exception of the high dose of 
CeO2 20% Gd (Figure 4.1). Cell differentials showed a similar recovery response and change in 
pulmonary cellular composition over the 84 day experiment. BAL composition changed from 
mainly macrophages to greater than 50% PMNs following exposure to both pure CeO2 
nanoparticles and CeO2 10% Gd (Figure 4.2). CeO2 20% Gd significantly lowered the amount of 
macrophages and significantly increased the amount of PMNs relative to PBS control treated 
animals but had a less severe effect on cellular composition 1 day post-exposure. Cell 
differentials showed that pure CeO2 nanoparticles had a significantly more pronounced effect on 
cellular composition compared to both CeO2 10% Gd and CeO2 20% Gd 7 days-post IT. By 84 
days post-exposure, BAL cellular composition returned to normal with the exception of the CeO2 
20% Gd, which caused a persistent effect on macrophages (Figure 4.2C).  
 
CeO2 Nanoparticle Effects on Pulmonary Toxicity and Phagocytic Cell Activity 
To determine the general toxic effects of CeO2 nanoparticle exposure, LDH levels were 
measured. Results demonstrate that damage peaked at 7 days-post exposure and returned to 
baseline damage by 84 days with the exception of CeO2 20%, which induced persistent damage 
(Figure 4.1A).  
 To determine phagocytic cell responsiveness and ROS production, EPR was utilized. 
Results indicate that phagocytic cells did not produce hydroxyl radicals in the absence of 
stimulus following exposure to any of the nanoparticles. However, results implicate that 
following treatment with Cr (VI), phagocytic cells from the three CeO2 groups at 7 days post-
exposure BAL produced significant levels of hydroxyl radicals compared to control treated 
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animal BAL cells. Results also indicate that CeO2 20% Gd significantly affected the ability of 
the phagocytic cells to respond to Cr (VI) 84 days-post exposure (Figure 4.3B). To further 
determine cellular activity a chemiluminescence (CL) assay was also utilized to measure ROS 
formation [40]. Results implicate that 1 day post-exposure, BAL cells significantly responded to 
zymosan stimulation, but over time BAL cells produced less ROS, and by 84 days post-exposure 
minimal ROS production was detected (Figure 4.3A).  
CeO2 Nanoparticle Exposure does not Result in Lipid Peroxidation (LPO) 
To determine free radical generation following nanoparticle exposure, LPO levels were 
determined in pulmonary tissue through measurement of MDA as an end product of persistent 
free radical damage. Results indicate that none of the nanoparticles induced significant LPO 
following pulmonary exposure, even 84 days post nanoparticle exposure (Figure 4.4).  
 
CeO2 Nanoparticle Effect on Inflammatory Cytokines  
To determine the inflammatory effects of CeO2 nanoparticles following pulmonary exposure, IL-
6, TNF-α, and IL-1β levels were detected in BAL fluid. Results indicate that all 3 nanoparticles 
did not induce significant inflammatory cytokines at any of the collected time points (Figure 
4.5).  
 
CeO2 Nanoparticle Effect on Collagen Formation in Lung Tissue 
To determine the effect of CeO2 nanoparticles on collagen formation in pulmonary tissue as a 
measurement of fibrosis initiation, a Sir-Col assay was utilized. Results indicate that 
nanoparticles caused a slight, but not significant increase in the amount of collagen in the lungs 
compared to control treated animals after 84 days post-exposure (Figure 4.6). 
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CeO2 Nanoparticle Effect on Cellular Influx and Fibrosis in Organs 
To determine the effect of CeO2 on alveolar macrophage and granular material accumulation in 
airways, H & E staining was utilized in lung sections from animals exposed to CeO2 nanoparticle 
materials 84 days post-exposure. Results indicate that all CeO2 nanomaterials caused an influx of 
macrophage (multifocal and diffuse) accumulation in the airways and mononuclear cell 
infiltration in the alveolar septae at both 0.5 mg/kg and 1 mg/kg doses compared to PBS treated 
animals. Lung lesion severity was generally greater in CeO2 20% Gd exposed animals, however 
there was not a consistent difference in the incidence or severity of lung changes among the 
animals, making determination of Gd impact difficult to interpret. No significant differences 
were noted between groups at equivalent doses but there was greater severity of lung lesions in 
animals exposed to 1 mg/kg compared to those exposed at 0.5 mg/kg (Figure 4.7A, Table 4.2). 
Sirius Red staining was also used on lung tissue to determine fibrosis initiation. Due to issues 
with fixation, the thickening noted by the stain is likely due impart to insufficient fixation and 
thus results that CeO2 induced fibrosis should be interpreted conservatively (Figure 4.7B, Table 
4.2). To determine the potential for CeO2 nanomaterials to cause damage in other organs, kidney 
and liver sections were stained with H & E. No significant changes in liver or kidney were noted 
(Table 4.2).  
 
Discussion 
As interest in CeO2 nanoparticles increase for industrial use, subsequent worker 
exposures will also increase. The purpose of this study was to determine if doping, a process 
which alters the valence state of Ce from 4+ to 3+, could decrease pulmonary toxicity of CeO2 
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nanoparticles. Specifically this study assessed how changes in valence state would affect 
pulmonary cellular influx, overall damage, inflammation, and fibrosis.  




 ratio from 16% in the 
pure CeO2 nanoparticles to 42% in the 10mol% doped and to 44% in the 20mol% doped [141]; 
however, in disagreement with the hypothesis, valence state did not have dramatic effects on the 
toxicity and reactivity of CeO2 nanoparticles following pulmonary instillation. While the overall 
effect of valence state on toxicity is unclear, it did appear that the CeO2 20% had persistent 
effects on cell influx and pulmonary damage not measured in animals exposed to pure CeO2 or 
CeO2 10% nanoparticles. Interestingly, CeO2 20% Gd had less of an immediate effect on LDH 
levels and cellular influx compared to pure CeO2 and CeO2 10% Gd (Figure 4.1). Alternatively, 
histopathology results indicate no significant difference in alveolar macrophage and granular 
material accumulation in alveoli between the CeO2 groups as expected from cell counting results 
(Figure 4.7A). As previously shown in our in vitro studies, valence state may be less important 
in determining nanoparticle reactivity since the valence states between the doped samples were 
very similar [141]. Therefore, the process of doping may prevent the nanoparticles from 
switching between valence states, a trait believed to be necessary for CeO2 to act as an 
antioxidant, which may affect their reactivity in the pulmonary environment. Further, an 
additional set of animals were exposed to Gd2O3 alone to ensure any effects measured were due 
to valence state or transitional ability, rather than the presence of Gd in the doped nanoparticle 
samples. Data implicates that Gd2O3 at a dose equivalent to the amount of Gd present in the 
CeO2 20% Gd sample (179 µg/kg), did not have significant effects on LDH or pulmonary cell 
influx by 84 day-exposure (data not shown). This implies that the effects caused by CeO2 20% 
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Gd are due to differences in surface reactivity and the nanoparticle’s valence state rather than the 
presence of Gd. 
Further, while other studies have shown CeO2 induces inflammatory cytokine activation 
following IT and inhalation exposure, none of the nanoparticle samples induced any significant 
inflammatory cytokines over the time course regardless of the severe pulmonary PMN and 
macrophage influx [40, 90] (Figure 4.5). The lack of cytokine activation may be due to 
differences in collection procedure, as cytokines from this study were measured directly from 
BALF rather than measured from media collected from plated BAL cells [40]. Additionally, 
differences in dose and exposure route may also account for a lack of inflammatory cytokine 
signaling measured in this study [90].  
To determine BAL phagocytic cell activity, EPR and chemiluminescence were 
implemented. As previously shown by Ma et al. (2011), CeO2 severely affects AM 
responsiveness at 1 day post-exposure; however, this response diminishes by 84 days post-
exposure [40]. To determine if this responsiveness also results in increased ROS production, 
cells were exposed to Cr (VI) and free radical production was assessed via EPR. Unlike 
chemiluminescence results, EPR results implicated that cells were more responsive 7 days post-
exposure. This may be due to a shift in phagocytic cell population from mainly PMNs to a 
mixture of PMNs and macrophages (Figure 4.2). Interestingly, by 84 days post-exposure, CeO2 
20% Gd exposed phagocytic BAL cells were significantly hindered in their ability to respond to 
Cr (VI) exposure compared to PBS control treated animals. By 84 days post-exposure, the cells 
in the BAL may be spent due to continued presence of CeO2 20% Gd nanoparticles, as noted by 
persistent damage (Figure 4.1), and therefore less responsive to further stimulus. Conversely, at 
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1 and 7 days post-exposure, the phagocytic cells are extremely responsive, as noted by 
chemiluminescence (Figure 4.3).   
Due to the effect of CeO2 on ROS, a downstream endpoint of ROS was assessed to 
determine the effect of valence state on CeO2 oxidative potential in vivo. Previous studies have 
shown that following CeO2 inhalation in CD1 mice, significant changes in LPO and glutathione 
levels occur [144]; however, our study implicates that none of the nanoparticles induced 
significant oxidative lung injury as measure by LPO formation in lung tissue (Figure 4.4). This 
is further supported by the lack of free radical production measured by ESR in the absence of Cr 
(VI) as a stimulus (data not shown). These differences may be due to the exposure route, dose, 
and in vivo model system.  
 To determine fibrosis initiation, a Sir-Col assay was utilized to measure collagen 
formation in lung tissue 84 days post-exposure as a supplementary assay to histochemical 
staining. Results implicate that CeO2 nanoparticles caused slight increases in collagen formation 
in lung tissue; however, these increases were not significant compared to 0 mg/kg treated control 
animals (Figure 4.6). Further, Sirius Red staining was used on lung tissue collected from 84 day 
post-exposure animals to detect changes in collagen[145]. While some thickening was visualized 
in the parenchyma near the ends of the lung lobes (Figure 4.7B), this is typically due to 
incomplete inflation during the fixation process rather than true fibrosis. Therefore, diagnoses of 
the alveolar septal thickening and fibrosis initiation should be interpreted conservatively. 
Previous in vivo studies, as well as retrospective human studies, have implicated that CeO2 
nanoparticles are capable of inducing pulmonary fibrosis [39, 138], therefore we anticipated a 
significant increase in lung collagen following exposure to the various CeO2 nanoparticles in this 
study. However, it is possible that due to the low doses used in our study compared to previous 
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in vivo studies that the animals were able to prevent long-term damage following exposure 
(Figure 4.1). Further, because human studies have shown that Ce remains in the pulmonary 
environment for more than 30 years [137], it is possible that an increased post-exposure time 
would have presented data that overtime the nanoparticles induce changes in collagen production 
and overall pulmonary health. 
Previous studies have suggested that valence state of CeO2 determines the potential 
toxicity of the nanoparticles; however, our findings do not indicate a direct correlation between 
valence state and toxicity over an 84 day time course. In fact, initial exposure to pure CeO2 
(greater Ce
4+
), induced greater damage initially, but doped CeO2 (greater Ce
3+
) caused persistent 
pulmonary injury. Due to differences between the two doped nanoparticles, it is likely that the 
transitional ability of CeO2, which is inhibited by Gd doping, determines its reactivity, rather 
than a specific valence state. Therefore, further studies are necessary to determine the 
mechanisms by which doped CeO2 causes less toxicity initially but induces persistent damage 
overtime. Further, numerous studies have reported that CeO2 has protective effects in vitro and in 
vivo against induced damage [56, 146, 147], therefore an in vivo study in which damage is 
induced prior to CeO2 exposure may allow elucidation of differences in reactivity between doped 
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Figure 4.1. Lactate dehydrogenase (LDH) levels and inflammatory cell counts in rat BALF 
over a time course of 84 days post-IT exposure. A. LDH concentration in BALF 1, 7, and 84 
days post-CeO2 nanoparticle exposure. Square (CeO2), circle (CeO2 10% Gd), triangle (CeO2 
20%) symbols represent mean ± SEM (n = 6-7 rats/group). PBS vehicle control animals are 
represented by hashed lines. *, p < 0.05 compared to 0 mg/kg controls on corresponding day, %, 
p < 0.05 compared to pure CeO2 on corresponding day.  B. From the BALF in A. total cells at 1, 
7, and 84 days post-exposure. C. As in B, except macrophages were counted. D. As in B, except 
PMNs were counted.  
 
- 104 - 
 
 
Figure 4.2. Cell differentials from BALF over a time course of 84 days post-IT exposure. A. 
Cells (200/rat) from day 1 post-CeO2 exposure were designated as macrophages, PMNs, 
lymphocytes, or eosinophils. Data is represented as percentage of cells and the bars represent the 
mean percentage ± SEM (n = 6-7 rats/group). *, p < 0.05 compared to 0 mg/kg controls on 
corresponding day, %, p < 0.05 compared to pure CeO2 on corresponding day. B. As in A. 
except data represents cells from 7 days post-exposure. C. As in A, except data represents cells 
from 84 days post-exposure. 
 







Figure 4.3. Phagocytic pulmonary cell activity over a time course of 84 days post-exposure. 
A. Response of AM from BALF over 84 days post exposure to zymosan challenge. ROS 
production was measured via chemiluminescence. *, p < 0.05 compared to 0 mg/kg controls on 
corresponding day, %, p < 0.05 compared to 0.5 mg/kg dose of same nanoparticle on 
corresponding day.  B. Phagocytic cell response to Cr (VI) challenge as measured by free radical 
production via EPR. BALF cells were combined with 200 mM DMPO, and 2mM Cr (VI) for 3 
minutes. EPR setting were: center field, 3485 G; scan width, 100 G; time constant, 0.41s; 
modulation amplitude, 1 G; receiver gain, 1 x 10
4
; frequency, 9.8 GHz; and power, 126.9 mW. 
 





Figure 4.4. Lipid peroxidation (LPO) production in pulmonary homogenates. A. LPO 
production, measured from lung homogenates from day 1 post-exposure pulmonary tissue. B. As 
in A, except pulmonary tissue from day 7 post-exposure. C. As in A, except pulmonary tissue 
from day 84 post-exposure. 
 
 




Figure 4.5. Cytokine concentration in BALF over a time course of 84 days post-exposure. 
A. Concentrations of TNF-α in BALF from CeO2 nanoparticle treated rats were quantified. B. As 













Figure 4.6. Collagen concentration in lung tissue 84 days post-nanoparticle exposure. 
Collagen levels were measured using a Sir-Col assay and are presented as fold change compared 















Figure 4.7. Histopathology results for pulmonary tissue after 84 day exposure to CeO2 20% 
Gd. A. H & E staining on pulmonary tissue showing alveolar macrophage and granular material 
in alveolar space. 20x. B. Sirius Red staining on pulmonary tissue to examine changes in 
collagen levels. 20x. Due to issues with inflation with fixative, interpretation of fibrosis initiation 
and septal thickening should be done conservatively.  
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5.1 Conclusions 
Overall these results demonstrate that shape, size, chemical composition, and valence state 
significantly alters the reactivity of tungstate and CeO2 nanoparticles in vitro. Altering the shape 
of the tungstate nanoparticles from sphere to wire had the greatest effect on cellular activity, 
specifically the ability of wires to induce ROS in RAW 264.7 cells (Figures 2.5 and 2.7). The 
shape also dramatically affected the particle-cellular interaction, as spheres were visualized 
within RAW 264.7 cells and spheres were only visualized clumped on the cell surface (Figures 
2.3 and 2.4). Further, wires caused significantly more cell death as measured by an MTT assay, 
while spheres caused a trend toward increased viability, possibly cellular proliferation. 
Surprisingly, altering the chemical composition from Ca to Sr or Br did not dramatically alter the 
reactivity of the nanoparticles as originally predicted with the exception of the ability of the 
nanomaterials to interact with cells. Specifically, Ba containing tungstate nanoparticles did not 
associate as well or as rapidly as the other tungstate nanomaterials (Figure 2.2). This may have 
been due to differences in size and therefore overall surface area of the different spheres, or may 
be due to differences in reactivity of Ba compared to Ca or Sr [26]. Further, the sizes of the 
nanowires were relatively similar, thus no differences in toxicity were measured between wire 
samples, whereas the size of the spheres were substantially different, yet no differences in 
toxicity were measured either (Figure 2.9). Our results support previous literature that shape of 
nanomaterials can dramatically affect toxicity, yet the study did not indicate that size or chemical 
composition affected reactivity as anticipated [1, 110].  
While the study of shape and size of nanomaterials is a heavily studied field of research 
to determine the properties that may provide novel safe nanomaterials for use in consumer 
products, determining how chemical composition, specifically altering the valence state, is an 
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under studied field. Our in vitro results implicate that altering the valence state of CeO2 
nanoparticles, which would potentially make them more suitable for engineering purposes [127], 
significantly altered their antioxidant abilities in both rat macrophage and epithelial cells 
(Figures 3.7 and 3.8). While the initial hypothesis was that doping would decrease antioxidant 
abilities due to a change in valence state, the findings demonstrate that transitional ability of 
CeO2 nanoparticles is more important in determining their protective effect. This was concluded 
based on the similarities between the valence state of the two doped samples and the statistically 
significant differences between their antioxidant potential measured via EPR. Further, the 
characterization data of the CeO2 nanoparticles implies that the process of doping did not alter 
the size or zeta potential of the nanoparticles in DM but did significantly alter the valence state. 
However, there was a type of saturation affect with doping as the difference in valence state 
between the 10% and 20% doped CeO2 only changed by approximately 1% (Table 3.1). Also, 
doping did appear to affect the agglomeration of the nanoparticles in DM as measured by DLS, 
possibly due to changes in surface properties of the nanomaterial (Tables 3.1 and 3.2). Our 
overall findings suggest that doping the nanomaterials decreases their antioxidant potential in 
vitro but does not affect their overall effects on RLE-6TN and NR8383 cell viability.   
Our in vivo CeO2 nanoparticle study indicates that altering the valence state and 
subsequent transitional ability of the nanomaterial significantly alters the pulmonary effect. 
Preliminary data suggests that pure CeO2 and CeO2 10% Gd nanoparticles induced greater 
toxicity and cell influx compared to CeO2 20% Gd after initial exposure. However, by 84 days 
post-exposure, pulmonary effects induced by CeO2 and CeO2 10% Gd were minimal and CeO2 
20% Gd induced significantly greater pulmonary influx than the other nanomaterials (Figure 
4.1). Surprisingly, none of the nanomaterials significantly induced ROS as measured via EPR 
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and downstream lipid peroxidation production (Figures 4.3 and 4.4) as expected from previous 
studies [144]. Further, because rare earth metals are known to induce rare earth metal 
pneumoconiosis and fibrosis [138, 148], pathology was completed on lung tissue collected from 
animals exposed to the various CeO2 nanoparticles and results showed no significant difference 
in cellular influx or fibrosis initiation between CeO2 groups. However, there was significant 
alveolar macrophage accumulation and granular material visualized in alveoli compared to PBS 
treated animals (Figure 4.7). Unfortunately, due to fixation of tissues, determination of fibrosis 
initiation was hindered (Figure 4.7B). Surprisingly, no damage was noted in liver and kidney 
sections as would have been expected due to potential nanomaterial translocation [149].  
Unfortunately, differences in reactivity between the nanomaterials was not pronounced in 
an in vivo model as anticipated, thus further studies must be conducted to determine the effect of 
valence state on CeO2 toxicity in order to manufacture CeO2 containing products safely. 
Overall, the data suggests that altering the size, shape, chemical composition, and valence 
state of nanomaterials may provide alternative, safe materials for use in consumer products. 
Additionally, since the process of doping increases the efficiency of materials for use in industry 
[127]but had minor effects on overall in vivo reactivity in these studies, this may provide a novel 
attribute that can be altered to improve nanomaterial efficiency while not affecting toxicity 
which may prove important as the use of nanomaterials in consumer products continues to grow. 
Specifically, the use of CeO2 nanoparticles in both biomedical applications [150] and as a diesel 
fuel additive [151] will increase the potential risk for human exposures, making determination of 
properties (size, shape, valence state) important in nanoparticle toxicity crucial.  
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5.2 Future Studies 
While the tungstate data indicates that these nanomaterials cause mild toxicity in vitro, it is 
known that in vivo results can often differ [152, 153]. Therefore, it is important to determine the 
effect of size, shape, and chemical composition of tungstate nanoparticles on toxicity in either an 
animal model or a more complex in vitro system. For example, co-culture in vitro models are 
seeing an increase in use due to their ability to more closely recapitulate an in vivo system. The 
co-culture models allow for cellular signaling between different cell types, potentially amplifying 
the cellular response to nanoparticles and modeling the effects recorded in vivo [154]. Further, 
our results indicated that wires were more reactive than spheres, most likely due to differences in 
cellular-interactions as discussed in chapter 2. Differences in reactivity between spheres and 
wires has been recorded with numerous other nanomaterials, as wires often penetrate cell walls 
and if long enough, are unsuccessfully phagocytosed, promoting continuous damage and cellular 
responses [155]. However, neither shape induced inflammatory cytokine activation, potentially 
due to the in vitro model utilized for the study as the wires were expected to promote 
inflammation. In vivo models may allow for better characterization of differences between these 
two nanomaterials, as it would be anticipated that the nanowires would induce more 
inflammation in vivo, transverse the pulmonary interstitial space, and cause toxicity as has been 
noted with other wire or belt shaped nanomaterials [156]. 
 Furthermore, studies to determine the effect of valence state on CeO2 antioxidant 
potential in different cell lines should be conducted. RLE-6TN and NR8383 cells, while 
providing a unique model for the rat pulmonary environment, do not respond well to induced 
ROS, making study of CeO2 potential antioxidant-like effects difficult. Therefore, RAW 264.7 
cells may represent an adequate in vitro model to determine antioxidant potential beyond the 3 
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minute EPR studies. In vitro studies have indicated that CeO2 is capable of reducing ROS 
through various mechanisms, including scavenging free radicals or upregulating cellular 
antioxidant systems [157, 158]. Thus, future studies should consider studying cellular antioxidant 
systems, such as superoxide dismutase, catalase, and glutathione reductase. Determining the role 
of valence state in oxidative or antioxidant potential of CeO2 nanoparticles may help develop 
safer materials for use in manufacturing of consumer products.  
Additionally, future studies should be conducted to further examine the effect of valence 
state on CeO2 nanoparticle toxicity, as our in vivo results were inconclusive. One potential 
method to test valence state would be in an animal model with high basal levels of oxidative 
stress or animals in which oxidative stress is induced. For example, Colon et al. (2010) presented 
data in which CeO2 nanoparticles protected gastrointestinal epithelium from radiation induced 
damage through antioxidant-like methods as well as inducing superoxide dismutase [136]. 
Further, Hirst et al. (2013) implicated that CeO2 nanoparticles acted similarly to N-acetyl 
cysteine, a known antioxidant, when mice were treated with carbon tetrachloride [159]. 
Therefore, a study in which damage was intentionally induced in the pulmonary environment 
prior to CeO2 nanoparticle exposure may allow for elucidation of the effect of valence state on 
potential toxicity or antioxidant potential in vivo. Further, because rare earth metals are known to 
induce rare earth metal pneumoconiosis and fibrosis [138, 148], pathology will be completed on 
lung tissue collected from animals exposed to the various CeO2 nanoparticles. Additionally, liver 
and kidney damage will be assessed as nanomaterials are known to translocate from the lungs 
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Dunnick KM, Sabolsky E, Leonard SS. The role of valence state in cerium oxide nanoparticle 
toxicity. Toxicologist 2015 Mar. 
 - Society of Toxicology Conference, 2015 Mar, San Diego, CA. 
 
*Dunnick KM, Sabolsky E, Leonard SS. Effects of doped cerium oxide nanoparticles on 
reactive oxygen species production.  
 - 8
th
 Conference on Metal Toxicity & Carcinogenesis, 2014 Oct, Albuquerque, NM. 
  
*Dunnick KM, Sabolsky E, Leonard SS. Effects of valence state on cerium oxide nanoparticle  
toxicity. 
 - American Association of Pharmaceutical Scientists Pittsburgh Regional Research  
 Forum, 2014 Sep, Pittsburgh, PA. 
 
Dunnick KM, Badding MA, Schwegler-Berry D, N. Marshall, E. Sabolsky and Leonard SS. 
Role of tungstate nanoparticles in the production of ROS and induction of cellular damage. 
- Allegheny-Erie Society of Toxicology Conference, 2014 May, Morgantown, WV. 
  
Dunnick KM, Badding MA, Schwegler-Berry D, Fix NR, Wong SS, and Leonard SS. 
Evaluation of tungstate nanoparticle cytotoxicity. Toxicologist 2014 Mar; 138(1): 517.  
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 - Society of Toxicology Conference, 2014 Mar, Phoenix, AZ. 
 
Dunnick KM, Badding MA, Fix NR, JM Patete Wong SS, and Leonard SS. Effect of size and 
shape of tungstate nanoparticles on cytotoxicity and ROS. 
 - American Association of Pharmaceutical Scientists WVU Regional Conference, 2013  
 June, Morgantown, WV. 
 
Dunnick KM, Badding MA, Fix NR, Wong SS, Castranova V, Leonard SS [2013]. Role of 
tungstate nanoparticles in the  production of ROS and induction of cellular damage. Toxicologist 
132:371:1747. 
 - Society of Toxicology Conference, 2013 Mar, San Antonio, TX 
 
Fix NR, Dunnick KM, Badding MA, Cummings KJ, Castranova V, and Leonard SS. Generation 
of reactive oxygen species by process materials from indium-tin oxide production. Toxicologist 
2013 Mar; 132(1):429.  
 - Society of Toxicology Conference, 2013 Mar, San Antonio, TX 
 
Badding MA, Fix NR, Dunnick KM, Cummings KJ, Castranova V, and Leonard SS. 
Macrophage toxicity in response to particles collected from indium-tin oxide production 
company. Toxicologist 2013 Mar; 132(1):427. 




2015-2016  Society of Toxicology, Nanotoxicology Student Representative  
2015    Outside Speaker Committee, IGERT Program, WVU 
2014-2015   Society of Toxicology, Nanotoxicology Vice-Student Representative 
   - Mentor-Mentee Match Program Committee member 
   - Specialty Section Awards Committee 
   - Specialty Section Proposal Review Committee member 
2014      Committee member; Science on Tap WVU outreach program 
2008-2011     Committee member; Student Alumni Association         
 
HONORS AND AWARDS  
 
2014      8
th
 Conference on Metal Toxicity & Carcinogenesis Student Travel Award 
2014      The Rho Chi Academic Honor Society in Pharmacy 
    Requires a minimum GPA of 3.0 in Pharmacy course work 
2014      Nanotoxicology Outstanding Graduate Student Award 
(Society of Toxicology) 
2014     Regulatory and Safety Evaluation Specialty Graduate Student Award  
     (Society of Toxicology) 
2014      WVU Dean Foundation Graduate Student Travel Award 
2013, 2014     National Science Foundation, IGERT fellowship recipient 
2013, 2014     WVU School of Pharmacy Graduate Student Travel Award     
2013      Society of Toxicology Graduate Student Travel Award 
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2010      Psi-Chi National Honor Society in Psychology 
    Requires a minimum GPA of 3.0 in Psychology major 
2010     Beta-Beta-Beta National Biological Honor Society 
    Requires a minimum GPA of 3.0 in Biology major 
2010- 2011     Dean’s List  
    Requires a minimum GPA of 3.33 
2007-2011    Vickroy Award (Annual award) 
The college’s highest scholarship, which is given to high  
school seniors graduating in the top 10% of their class 
 
SERVICE AND VOLUNTEER EXPERIENCE 
 
2015, June                  Camp Muffly, Childrens Day Camp, Volunteer  
2015, Feb                    WV Science Bowl Volunteer 
2015, Jan Trinity Christian School Science Fair Judge 
2015                            Ad Hoc reviewer, J. Toxicology and Environmental Health, part A 
2014, Dec Ronald McDonald House volunteer 
2014, May Boys and Girls club volunteer 
2014-2015 Children’s Discovery Museum of WV NanoDays Volunteer 
2014, Apr     WV Science Bowl Volunteer 
2010    Freshman biology tutor 
2005-2011    American Cancer Society 
Yearly Relay for Life Team Captain 
 
PROFESSIONAL ORGANIZATION MEMBERSHIPS 
 
2012-present  Society of Toxicology 
Member of: Nanotoxicology Specialty Section, Inhalation 
and Respiratory Specialty Section, Women in Toxicology 
Special Interest Group 
2012-present      Allegheny-Erie Regional Chapter, Society of Toxicology 
2012-present      American Association of Pharmaceutical Scientists 
 
